Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             695 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A57 Adrenal and androgen synthesis in the aging male Carlström, K.
1996
27 S1 p. 18-
1 p.
artikel
2 A04 A European trial on secondary prevention of cardiovascular disease Schenck-Gustafsson, K
1996
27 S1 p. 2-
1 p.
artikel
3 A66 Alternative managements to HRT Aso, T
1996
27 S1 p. 21-
1 p.
artikel
4 A10 An Asian perspective of the menopause Punyahotra, S
1996
27 S1 p. 3-
1 p.
artikel
5 A28 Androgens and bone function Davis, Susan
1996
27 S1 p. 8-
1 p.
artikel
6 A27 Androgens during the female lifespan Buckler, H.M.
1996
27 S1 p. 8-
1 p.
artikel
7 A08 A psychological approach to management of the menopause Collins, Aila
1996
27 S1 p. 3-
1 p.
artikel
8 A62 A review of the problem of compliance Whitehead, MI
1996
27 S1 p. 20-
1 p.
artikel
9 A23 Biology of endometrium Rutanen, E-M
1996
27 S1 p. 7-
1 p.
artikel
10 A12 Bone structure and function in relation to aging and the menopause Mosekilde, Lis
1996
27 S1 p. 4-
1 p.
artikel
11 A60 Cardiovascular effects of sex steroids Collins, P
1996
27 S1 p. 19-
1 p.
artikel
12 A58 Cellular mechanisms of action for estrogen in cardio protection Gorodeski, GI
1996
27 S1 p. 18-19
2 p.
artikel
13 A13 Clinical aspects of oestrogens and osteoporosis Eriksen, E.F.
1996
27 S1 p. 4-
1 p.
artikel
14 A25 Clinical implications for the endometrium of hormone replacement therapy Pickar, JH
1996
27 S1 p. 7-8
2 p.
artikel
15 A02 Clinical medicine and clinical trials: Reflections on a shotgun marriage Bush, Trudy L.
1996
27 S1 p. 1-
1 p.
artikel
16 A61 Do progestogens attenuate CVS benefits of oestrogens? Göran, Samsioc
1996
27 S1 p. 20-
1 p.
artikel
17 A43 Effect of soy on menopausal symptoms Wilcox, G
1996
27 S1 p. 13-
1 p.
artikel
18 A44 Effects of hormonal steroids on brain cells Garcia-Segura, LM
1996
27 S1 p. 13-14
2 p.
artikel
19 A59 Effects of HRT on lipids and lipoprotein metabolism de Melo, Nilson Roberto
1996
27 S1 p. 19-
1 p.
artikel
20 A40 Epidemiology of phyto-oestrogens, cancer and other diseases Griffiths, K
1996
27 S1 p. 12-
1 p.
artikel
21 A03 Estrogen replacement and progression or regression of coronary atherosclerosis Herrington, DM
1996
27 S1 p. 1-
1 p.
artikel
22 A47 Estrogen treatment for senile dementia-Alzheimer's type Honjo, H
1996
27 S1 p. 15-
1 p.
artikel
23 A16 Extragenital effects of hormones Metka, M.M.
1996
27 S1 p. 5-
1 p.
artikel
24 A55 Factors determining androgen levels in aging males Vermeulen, A
1996
27 S1 p. 17-18
2 p.
artikel
25 A22 Hormonal activity in the endometrium Salamonsen, LA
1996
27 S1 p. 6-7
2 p.
artikel
26 A19 Hormonal control of cell proliferation in the breast and breast cancer Musgrove, EA
1996
27 S1 p. 5-
1 p.
artikel
27 A20 Hormone replacement therapy (HRT) and breast cancer Hulka, BS
1996
27 S1 p. 6-
1 p.
artikel
28 A49 Hormone replacement therapy (HRT) in diabetes Stevenson, JC
1996
27 S1 p. 15-
1 p.
artikel
29 A35 Hormones and depression Studd, J.W.W.
1996
27 S1 p. 10-11
2 p.
artikel
30 A36 Hormones and libido Graziottin, Alessandra
1996
27 S1 p. 11-
1 p.
artikel
31 A63 How can compliance be improved in a general practice setting? Roberts, PJ
1996
27 S1 p. 20-
1 p.
artikel
32 A51 HRT following myocardial infarct, thrombosis & hypertension Dines, A
1996
27 S1 p. 16-
1 p.
artikel
33 A65 Improving HRT compliance during the next decade MacLennan, A.H.
1996
27 S1 p. 21-
1 p.
artikel
34 A09 Lifestyle approach to management of the menopause Guthrie, JR
1996
27 S1 p. 3-
1 p.
artikel
35 A31 Menopausal medicine under difficult conditions Wasti, S.
1996
27 S1 p. 9-
1 p.
artikel
36 A33 Menopausal medicine under difficult conditions Moskovic, T
1996
27 S1 p. 10-
1 p.
artikel
37 A32 Menopausal medicine under difficult conditions: The Philippine experience Jalbuena, J.R.
1996
27 S1 p. 9-10
2 p.
artikel
38 A52 Menopause transition Morse, Carol A
1996
27 S1 p. 16-
1 p.
artikel
39 A34 Neuroendocrine changes and climaterium Genazzani, A.R.
1996
27 S1 p. 10-
1 p.
artikel
40 A46 Neurosteroids: New roles Baulieu, EE
1996
27 S1 p. 14-
1 p.
artikel
41 A53 New delivery systems for hormone replacement therapy Fraser, Ian S
1996
27 S1 p. 17-
1 p.
artikel
42 A11 Oestrogen and bone cells Stern, PH
1996
27 S1 p. 3-
1 p.
artikel
43 A39 Oestrogens and dementia Henderson, VW
1996
27 S1 p. 12-
1 p.
artikel
44 A14 Other hormones acting on osteoporosis Lindsay, R
1996
27 S1 p. 4-
1 p.
artikel
45 A38 Phytoestrogens Hughes, CL
1996
27 S1 p. 12-
1 p.
artikel
46 A41 Phytoestrogens from biochemistry to prevention of cancer and other diseases Adlercreutz, H.
1996
27 S1 p. 12-13
2 p.
artikel
47 A01 Pieter van Keep memorial lecture: Menopause—A modern perspective from a controversial history Utian, Wulf H.
1996
27 S1 p. 1-
1 p.
artikel
48 A42 Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats Lamartiniere, C.A.
1996
27 S1 p. 13-
1 p.
artikel
49 A21 Progestogen use and breast cancer Sitruk-Ware, R
1996
27 S1 p. 6-
1 p.
artikel
50 A18 Role of hormones in human breast development: The menopausal breast Russo, J
1996
27 S1 p. 5-
1 p.
artikel
51 A48 Sex hormones and chronic neurological disorders Somerville, ER
1996
27 S1 p. 15-
1 p.
artikel
52 A37 Tachyphylaxis: A novel approach to management Wilson, AJ
1996
27 S1 p. 11-
1 p.
artikel
53 A56 The benefits and risks of androgen therapy in the aging male Gooren, L.J.G.
1996
27 S1 p. 18-
1 p.
artikel
54 A54 The consequences of longevity Lachowsky, M
1996
27 S1 p. 17-
1 p.
artikel
55 A17 The development of a new strategy to prevent diseases of the menopause in postmenopausal women Jordan, V. Craig
1996
27 S1 p. 5-
1 p.
artikel
56 A45 The effects of estrogen on primate brain circuitry Naftolin, F.
1996
27 S1 p. 14-
1 p.
artikel
57 A30 The media and menopause McCarthy, Wendy
1996
27 S1 p. 9-
1 p.
artikel
58 A50 The menopause, oestrogens and arthritis Spector, TD
1996
27 S1 p. 15-
1 p.
artikel
59 A15 The politics of menopause Albery, N.
1996
27 S1 p. 4-
1 p.
artikel
60 A07 The role of menopause clinics Smith, M.
1996
27 S1 p. 2-
1 p.
artikel
61 A29 The use of androgens in the postmenopause-evidence from clinical studies Sherwin, BB
1996
27 S1 p. 8-
1 p.
artikel
62 A67 The 1996 who report on the menopause: Its implications for research in the clinical, epidemiological and social sciences Burger, H
1996
27 S1 p. 22-
1 p.
artikel
63 A05 The women's health initiative clinical trial and observational study Johnson, SR
1996
27 S1 p. 2-
1 p.
artikel
64 A24 Ultrasound and the endometrium in postmenopausal women Grimwade, JC
1996
27 S1 p. 7-
1 p.
artikel
65 A26 Unresolved issues in endometrial cancer and postmenopausal hormone therapy Weiss, NS
1996
27 S1 p. 8-
1 p.
artikel
66 Author index 1996
27 S1 p. 221-233
13 p.
artikel
67 A06 What we have learned about menopause from epidemiological studies McKinlay, SM
1996
27 S1 p. 2-
1 p.
artikel
68 A64 Womens knowledge of the menopause and HRT and their sources of information Godfree, VA
1996
27 S1 p. 20-21
2 p.
artikel
69 209 Cervical displasia in postmenopausal women Özaksit, G.
1996
27 S1 p. 182-
1 p.
artikel
70 F191 A beneficial rise in HDL cholesterol by lower frequency of neta administration in sequential HRT van der Mooren, MJ
1996
27 S1 p. 103-104
2 p.
artikel
71 F230 A cohort study of hormone replacement therapy given to women previously treated for breast cancer Dew, JE
1996
27 S1 p. 115-
1 p.
artikel
72 F231 A controlled trial of isoflavones for menopausal symptoms Eden, JA
1996
27 S1 p. 115-
1 p.
artikel
73 F017 Adverse endometrial effects during long cycle hormone replacement therapy Cerin, Å.
1996
27 S1 p. 48-
1 p.
artikel
74 F060 Age and race relationship of women presenting with colle's or trocranteric fractures Premitha, D
1996
27 S1 p. 61-
1 p.
artikel
75 F019 A longitudinal, comparative study of the effect of kliogest and livial on plasma lipids in post-menopausal women Sheppard, B.L.
1996
27 S1 p. 48-
1 p.
artikel
76 F044 A meta-analysis of the effect of estrogen on urogenital atrophy Cardozo, L
1996
27 S1 p. 56-
1 p.
artikel
77 F014 A new regimen of continuous combined oral hormone replacement therapy with oscillating doses of estrogen Koninckx, PR
1996
27 S1 p. 46-
1 p.
artikel
78 F106 A new transdermal noretihisterone acetate: Efficacy and potentiality of a once a week form Raynaud, J-P
1996
27 S1 p. 75-
1 p.
artikel
79 F222 Antiresorptive effect of transdermal estradiol on bone mass in healthy, osteoporotic and fractured postmenopausal women Moskovic, T
1996
27 S1 p. 113-
1 p.
artikel
80 F112 Applied relaxation - a behavioural treatment for vasomotor symptoms among postmenopausal women Nedstrand, EE
1996
27 S1 p. 77-
1 p.
artikel
81 F158 A prospective study of bone loss in perimenopausal australian-born women Guthrie, JR
1996
27 S1 p. 92-
1 p.
artikel
82 F170 A randomised controlled trial of hormone replacement therapy in breast cancer patients — A feasibility study Marsden, J
1996
27 S1 p. 96-
1 p.
artikel
83 F141 A randomized study to compare the efficacy of a vaginal ring (estradiol) with a vaginal pessary (estriol) in postmenopausal women (PMW) with urinary symptoms (US) Lose, G
1996
27 S1 p. 87-
1 p.
artikel
84 F034 A screening model for osteoporosis using dermal skin thickness and bone densitometry Brincat, M.P.
1996
27 S1 p. 53-
1 p.
artikel
85 F220 Assessment of bone loss in post menopausal women with hormone replacement therapy by urinary markers of C-telopeptide I collagene. A longitudinal study Tabaste, J.L.
1996
27 S1 p. 112-
1 p.
artikel
86 F007 A study of the effect of kliogest and livial on coagulation and fibrinolysis in post-menopausal women Bonnar, J.
1996
27 S1 p. 44-
1 p.
artikel
87 F006 A study of the effect of kliogest and livial on quality of life in post-menopausal women Joyce, M.
1996
27 S1 p. 44-
1 p.
artikel
88 F183 A survey of hormone replacement therapy awareness and usage following hysterectomy Panay, N.
1996
27 S1 p. 101-
1 p.
artikel
89 F002 Attitude of physicians towards HRT. Analysis of a pre-test Rozenberg, S.
1996
27 S1 p. 43-
1 p.
artikel
90 F090 Baseline characteristics do not affect the response to raloxifene hydrochloride in Japanese women with osteoporosis Morii, H
1996
27 S1 p. 70-71
2 p.
artikel
91 F228 Bleeding pattern in HRT regimens with continuous estradiol valerate (EV) and sequential chlormadinone acetate (CMA) Gräser, T
1996
27 S1 p. 114-
1 p.
artikel
92 F070 Bleeding-related drop-out incidence is significantly lower during treatment with livial than with kliogest Christau, S
1996
27 S1 p. 64-
1 p.
artikel
93 F131 Body image, hormone replacement therapy, and sexual function, among postmenopausal women Deeks, AA
1996
27 S1 p. 83-
1 p.
artikel
94 F085 Bone density after combined continuous HRT-advantage of L-norgestrel at the hip site? Gutteridge, DH
1996
27 S1 p. 69-
1 p.
artikel
95 F033 Bone density and skin thickness changes in patients on long tern steroid therapy treated with long term hormone replacement therapy Baron, Y. Muscat
1996
27 S1 p. 52-
1 p.
artikel
96 F029 Bone density, blood viscosity and body mass index in the postmenopausal women Kaibara, M
1996
27 S1 p. 51-
1 p.
artikel
97 F217 Bone loss in postmenopausal women after renal transplantation: HRT versus calcitriol treatment Ciammella, M.
1996
27 S1 p. 111-
1 p.
artikel
98 F088 Bone loss in women over 60 years prevented by ultra-low doses of 17-β estradiol Naessen, T
1996
27 S1 p. 70-
1 p.
artikel
99 F133 Bone mineral density (BMD) at lumbar spine and femoral neck in hysterectomised women treated with chronic oestradiol implantation Purdie, DW
1996
27 S1 p. 84-
1 p.
artikel
100 F159 Bone turnover markers and bone density across the menopausal transition Ebeling, PR
1996
27 S1 p. 92-
1 p.
artikel
101 F169 Breast cancer and treatment-induced menopause: Implications for health education Weiss, B.
1996
27 S1 p. 96-
1 p.
artikel
102 F001 Canadian and American differences in the experience of menopause Cobb, Janine O'Leary
1996
27 S1 p. 43-
1 p.
artikel
103 F161 Can the fast bone loss in osteoporotic patients be stopped with vitamin D metabolites as an alternative to estrogens? Dambacher, M.A.
1996
27 S1 p. 93-
1 p.
artikel
104 F114 CGRP-a neuropeptide responsible for vasomotor symptoms around menopause? Wyvon, YM
1996
27 S1 p. 78-
1 p.
artikel
105 F011 Changes in coagulation proteins in postmenopausal women treated with estring® (a new type of intravaginal ring releasing continuous estradiol 17 beta) compared to conjugated equine estrogens in a vaginal cream Hickox, PG
1996
27 S1 p. 46-
1 p.
artikel
106 F175 Changes in systemic hemodynamic parameters during handgrip: Relation to the menstrual cycle, to the postmenopause and to the ERT Cicinelli, E
1996
27 S1 p. 98-
1 p.
artikel
107 F057 Characteristics of menopause among Chinese women Oin-sheng, Ge
1996
27 S1 p. 60-
1 p.
artikel
108 F104 Chlormadinone acetate(CA) to micronized progesterone(MP) in the sequential hormonal replacement therapy (HRT) of the menopause Pélissier, C.
1996
27 S1 p. 74-
1 p.
artikel
109 F150 Clinical grouping of hormone replacement therapy Hutton, J
1996
27 S1 p. 90-
1 p.
artikel
110 F129 Cognitive behaviour therapy for depressed mood in menopausal women Greene, J.G.
1996
27 S1 p. 83-
1 p.
artikel
111 F165 Combined oral conjugated equine estrogen and LNG IUS as a hormonal replacement therapy regimen in perimenopausal women Hampton, NRE
1996
27 S1 p. 94-
1 p.
artikel
112 F105 Compared single dose pharmacokinetics of S21102, a new estradiol transdermal patch with two marketed drug products Rocher, I
1996
27 S1 p. 75-
1 p.
artikel
113 F073 Comparing the effect of combined oestrogen and progesterone therapy with the effect of simvastatin therapy on lipid levels in postmenopausal women with hypercholesterolaemia Darling, G.M.
1996
27 S1 p. 65-
1 p.
artikel
114 F176 Comparison of the effects of transdermal and oral HRT on ambulatory blood pressure in postmenopausal women Paakkari, I
1996
27 S1 p. 98-
1 p.
artikel
115 F080 Comparison of transvaginal ultrasonography and endometrial biopsy in postmenopausal women on different HRT regimens Hänggi, W
1996
27 S1 p. 68-
1 p.
artikel
116 F218 Comparison of two doses of conjugated estrogen on postmenopausal bone loss in the lumbar spine assessed by DXA Soda, M.
1996
27 S1 p. 111-112
2 p.
artikel
117 F123 Comparison of uterine and carotic artery pulsatility index during oral or transdermal HRT Cacciatore, B
1996
27 S1 p. 81-
1 p.
artikel
118 F202 Continuous oestrogen/progestogen HRT and novel mechanisms by which the risk of CHD may be reduced Ahmed, AIH
1996
27 S1 p. 107-
1 p.
artikel
119 F229 Continuous premarin and medroxyprogesterone acetate vs tibolone (livial): A comparative study of effects on carbohydrate metabolism, safety, and acceptability-an interim report Gross, BA
1996
27 S1 p. 114-115
2 p.
artikel
120 F101 Controlled study of metabolic effects of estrogen-progestogen and tibolone over 2 years on postmenopausal women Milner, M
1996
27 S1 p. 74-
1 p.
artikel
121 F147 Control of menopausal symptoms in women denied oestrogen using unopposed megestrol acetate Ekevall, K
1996
27 S1 p. 89-
1 p.
artikel
122 F130 Correlation of sex-hormones to sex-role identification and vasomotor complaints during the menopausal transition in healthy norwegian women Overlie, I
1996
27 S1 p. 83-
1 p.
artikel
123 F032 Cross-over comparison of skin irritation with two transdermal oestradiol patches in women with a history of patch site skin irritation Ross, D
1996
27 S1 p. 52-
1 p.
artikel
124 F031 Development of a photographic digital imaging technique for measuring skin irritation with transdermal patches Ross, D
1996
27 S1 p. 52-
1 p.
artikel
125 F162 Diagnosis of osteoporosis by ultrasound densitometrie-comparative data from a pilot study Beckmann, MW
1996
27 S1 p. 93-94
2 p.
artikel
126 F233 Does hormone replacement therapy (HRT) have a mood elevating effect in asymptomatic menopausal women? Ross, LA
1996
27 S1 p. 116-
1 p.
artikel
127 F064 Do ovarian stimulation treatments modify the age of menopause and of appearance of climateric symptoms Demoulin, A.
1996
27 S1 p. 62-
1 p.
artikel
128 F171 Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen Fallo, L.
1996
27 S1 p. 97-
1 p.
artikel
129 F193 Do women's premenstrual symptoms and their mother's climacteric history predict their own vasomotor symptoms? Wyon, YA
1996
27 S1 p. 104-
1 p.
artikel
130 F066 Early menopause-problems faced by women with early loss of ovarian function McCall, YK
1996
27 S1 p. 63-
1 p.
artikel
131 F136 Effectiveness of tibolone X placebo in postmenopausal women Wender, MCO
1996
27 S1 p. 85-
1 p.
artikel
132 F097 effect of hormone replacement on insulin sensitivity in women after oophorectomy Roberts, RN
1996
27 S1 p. 73-
1 p.
artikel
133 F037 Effect of 17β-oestradiol on endothelin-1 release by human umbilical vein endothelial cells Wingrove, CS
1996
27 S1 p. 53-
1 p.
artikel
134 F036 Effect of topical ammonium lactate on epidermal atrophy in postmenopausal women Faure, M
1996
27 S1 p. 53-
1 p.
artikel
135 F093 effects of acute and short-term estradiol administration on serum nitric oxide levels in postmenopausal women Cicinelli, E
1996
27 S1 p. 71-72
2 p.
artikel
136 F115 Effects of estrogens, tamoxifen, progestins, androgens and dietary soy on the mammary gland and endometrium of macaques Cline, JM
1996
27 S1 p. 78-
1 p.
artikel
137 F050 Effects of hormone replacement therapy on duplexsonographic quantification of carotid atherosclerosis in postmenopausal women Römer, T
1996
27 S1 p. 58-
1 p.
artikel
138 F211 Effects of 3 months low-dose HRT on parameters of cardiac function in postmenopausal women Mijatovic, V.
1996
27 S1 p. 109-
1 p.
artikel
139 F124 Effects of oral norgestrel and vaginal progesterone on uterine artery pulsatility index in oestrogen-treated postmenopausal women Ross, D
1996
27 S1 p. 81-
1 p.
artikel
140 F098 Effects of oral or transdermal oestradiol combined with cyclical oral norethisterone acetate on insulin and glucose metabolism in postmenopausal women Spencer, CP
1996
27 S1 p. 73-
1 p.
artikel
141 F187 Effects of tibolone compared with a cyclical oestrogen/progestogen regimen on lipoproteins Farish, E
1996
27 S1 p. 102-
1 p.
artikel
142 F154 Efficacy and tolerability benefits of new matrix patches (estraderm MX® 50 and 100) in the treatment of moderate-to-severe postmenopausal symptoms Snijders, MPML
1996
27 S1 p. 91-
1 p.
artikel
143 F155 Efficacy and tolerability of a new low dose matrix patch (estraderm MX® 25) in the treatment of mild-to-moderate menopausal symptoms Chevallier, O
1996
27 S1 p. 91-
1 p.
artikel
144 F153 Efficacy and tolerability of a new oestradiol matrix patch (estraderm MX® 50) in the treatment of moderate-to-severe hot flushes Crosignani, PG
1996
27 S1 p. 91-
1 p.
artikel
145 F079 Endometrial assessment of women on continuous combined HRT Calder, AL
1996
27 S1 p. 68-
1 p.
artikel
146 F084 Endometrial histology, in long-cycle HRT, for three years Englund, DE
1996
27 S1 p. 69-
1 p.
artikel
147 F092 Enhanced nitric oxide formation by 17β-estradiol in vascular smooth muscle may explain its ability to attenuate vasoconstriction Binko, J
1996
27 S1 p. 71-
1 p.
artikel
148 F168 Evaluation of crinone®, a transvaginally administered progesterone containing bioadhesive gel, in women with secondary amenorrhea Warren, MP
1996
27 S1 p. 95-96
2 p.
artikel
149 F208 Experiences of menopause amongst greek-speaking women in an australian city Kafanelis, B.
1996
27 S1 p. 108-
1 p.
artikel
150 F209 Factors associated with health care utilisation during the menopausal transition: A longitudinal study Donnelly, VS
1996
27 S1 p. 109-
1 p.
artikel
151 F063 Genetics of the age at menopause in a large Australian twin study Christiansen, BJ
1996
27 S1 p. 62-
1 p.
artikel
152 F110 Health status and climacteric complaints in perimenopausal women in Hong Kong Chan, SG
1996
27 S1 p. 77-
1 p.
artikel
153 F068 Histopathology and bleeding patterns of continuous combined HRT administered transdermally and orally Mattson, LA
1996
27 S1 p. 63-
1 p.
artikel
154 F181 Hormone replacement therapy after transcervical resection of the endometrium Istre, Olav
1996
27 S1 p. 100-
1 p.
artikel
155 F207 Hormone replacement therapy and previous use of oral contraceptives among swedish women Brynhidsen, JO
1996
27 S1 p. 108-
1 p.
artikel
156 F195 Hormone replacement therapy and psychological symptoms: A comparison of tibolone and conjugated oestrogens Alder, E.M.
1996
27 S1 p. 105-
1 p.
artikel
157 F204 Hormone replacement therapy improves glucose metabolism and plasma lipids in postmenopausal women with non-insulin dependent diabetes mellitus Andersson, B
1996
27 S1 p. 107-
1 p.
artikel
158 F087 Hormone replacement therapy improves postural balance function in menopausal women Naessen, T
1996
27 S1 p. 70-
1 p.
artikel
159 F194 Hot flushes, menstrual status and hormone levels in a population-based sample of Australian-born midlife women Guthrie, JR
1996
27 S1 p. 105-
1 p.
artikel
160 F215 How does estrogen replacement therapy affect cardiac function of flushers and non-flushers Beljic, T
1996
27 S1 p. 111-
1 p.
artikel
161 F192 HRT and CVD: Progestin induced chances in lipid metabolism may be counterbalanced by a long-cycle strategy Andersen, LF
1996
27 S1 p. 104-
1 p.
artikel
162 F184 Hysterectomy, hormone therapy and self perception of menopausal status Taffe, JR
1996
27 S1 p. 101-
1 p.
artikel
163 F056 Impact of smoking on bone mineral density of menopausal patients Celikkanat, H.
1996
27 S1 p. 60-
1 p.
artikel
164 F116 Important androgenic component in the stimulatory effect of dehydroepiandrosterone (DHEA) on bone density in the rat Martel, C
1996
27 S1 p. 79-
1 p.
artikel
165 F094 improved nitric oxide synthesis in postmenopausal women treated with 17β-estradiol valerate-evidence for responders and non-responders Imthurn, B
1996
27 S1 p. 72-
1 p.
artikel
166 F196 Improvement of climateric symptoms prior to HRT Oldenhave, A.
1996
27 S1 p. 105-
1 p.
artikel
167 F117 Influence of hormone replacement therapy on gonadotropin pulsatility in postmenopausal women Vujovic, S
1996
27 S1 p. 79-
1 p.
artikel
168 F139 Influence of treatment satisfaction and quality of life on the overall effectiveness of two topical oestrogen treatments for atrophic vaginitis Burnet, R
1996
27 S1 p. 86-
1 p.
artikel
169 F075 Influence of type and dose of oestrogen on plasma lipids in post-menopausal women Harvey, PJ
1996
27 S1 p. 66-
1 p.
artikel
170 F135 Influence of vitamin D receptor polymorphism on postmenopausal bone density and response to HRT Jagger, C
1996
27 S1 p. 85-
1 p.
artikel
171 F120 Inhibitory effect of a new non-steroidal pure antiestrogen (EM-800) in combination with DHEA on human ZR-75-1 breast tumors in nude mice Couillard, S
1996
27 S1 p. 80-
1 p.
artikel
172 F018 International long-term randomised controlled trial of hormone replacement therapy-UK feasibility study Vickers, MR
1996
27 S1 p. 48-
1 p.
artikel
173 F163 Intrauterine progestin therapy in HRT: Results of a four-year follow-up study Suhonen, S.P.
1996
27 S1 p. 94-
1 p.
artikel
174 F111 Is hormone replacement therapy a risk factor for low back pain among postmenopausal women? Brynhildsen, JO
1996
27 S1 p. 77-
1 p.
artikel
175 F091 I.V. Administration of conjugated estrogen improves endothelium dependent flow mediated vasodilatation in postmenopausal women Schenck-Gustafsson, K
1996
27 S1 p. 71-
1 p.
artikel
176 F156 Lack of microbial proliferation and phototoxic potential of a new oestradiol matrix patch (Estraderm MX®) Hüls, GE
1996
27 S1 p. 91-
1 p.
artikel
177 F040 Levormeloxifene, a non-steroidal estrogen receptor therapetic, reduces serum cholesterol and prevents aortic cholesterol accumulation in cholesterol fed rabbits Holm, P.
1996
27 S1 p. 54-
1 p.
artikel
178 F108 Long-term clinical performance of two different HRT regimens: Oral combined estrogen progestin and transdermal estrogen with sequential progestin Luotola, H
1996
27 S1 p. 76-
1 p.
artikel
179 F078 Long-term comparison three: Hormone replacement therapies on serum lipids and lipoprotein(a) Hänggi, W
1996
27 S1 p. 67-
1 p.
artikel
180 F023 Long-term effects of dydrogesterone and medroxyprogesterone on lipoprotein indicators of cardiovascular risk in postmenopausal women Gelfand, M.M.
1996
27 S1 p. 49-
1 p.
artikel
181 F107 Long-term follow up of postmenopausal patients treated with estradiol patches-eight year experience Feridun, M
1996
27 S1 p. 75-76
2 p.
artikel
182 F096 low-dose HRT reduces vascular resistance in the central retinal artery van Baal, W.M.
1996
27 S1 p. 72-
1 p.
artikel
183 F226 Management of endometrial polyps in menopause patients under HRT Maia Jr, H.
1996
27 S1 p. 114-
1 p.
artikel
184 F065 Management of the woman with premature menopause Norman, RJ
1996
27 S1 p. 62-63
2 p.
artikel
185 F022 Mechanisms regulating low density lipoprotein levels in postmenopausal women Karjalainen, AH
1996
27 S1 p. 49-
1 p.
artikel
186 F126 Medroxyprogesterone acetate (MPA) but not natural progesterone (P) reverses the effect of estradiol 17β (E2) upon exercise induced myocardial ischemia. A double-blind cross-over study Rosano, G.M.C.
1996
27 S1 p. 82-
1 p.
artikel
187 F146 Megestrol acetate to treat vasomotor symptoms Rees, MCP
1996
27 S1 p. 88-
1 p.
artikel
188 F197 Menopausal symptoms and general well-being: The effect of hormone replacement therapy in 2 groups of chinese women Tang, G
1996
27 S1 p. 105-
1 p.
artikel
189 F003 Menopause and low-income women of ethnic minorities: The significance of social class and cultural difference Weiss, B.
1996
27 S1 p. 43-
1 p.
artikel
190 F180 Menopause, HRT and blood pressure: A cross-sectional analysis of 3,036 women Gambacciani, M
1996
27 S1 p. 100-
1 p.
artikel
191 F203 Metabolic effects of estradiol-norethisterone acetate treatment in postmenopausal women Falkeborn, M
1996
27 S1 p. 107-
1 p.
artikel
192 F099 metabolic effects of 12-month percutaneous DHEA replacement therapy in postmenopausal women Diamond, P
1996
27 S1 p. 73-
1 p.
artikel
193 F199 Metabolic risk markers in postmenopausal women with coronary heart disease Stevenson, JC
1996
27 S1 p. 106-
1 p.
artikel
194 F038 Modulation of vegf expression in cultured human blood vessels: Effect of 17β-oestradiol Akkad, AA
1996
27 S1 p. 54-
1 p.
artikel
195 F127 Mood and menopause: Update 1992–1996 Holte, A
1996
27 S1 p. 82-
1 p.
artikel
196 F083 Morphometric and immunohistological evaluation of the endometrium of menopausal women treated by oestrogen and crinone, a new slow-release vaginal progesterone Casanas-Roux, F
1996
27 S1 p. 69-
1 p.
artikel
197 F200 Multicentre evaluation of 17-β oestradiol and dydrogesterone HRT on cardiovascular risk Crook, D
1996
27 S1 p. 106-
1 p.
artikel
198 F008 No influence of hormone replacement therapy on the risk of thrombotic and haemorrhagic stroke-results from a nationwide case-control study Pedersen, AT
1996
27 S1 p. 45-
1 p.
artikel
199 F223 Norethisterone and progesterone are potent comparable inducers of endometrial PAI-1 activity Bertil, Casslén
1996
27 S1 p. 113-
1 p.
artikel
200 F119 Occurrence and modification of intimal hyperplasia by the changes in female hormones Azuma, H
1996
27 S1 p. 80-
1 p.
artikel
201 F076 17β-Oestradiol continuous combined with dydrogesterone reduces LP(a) in postmenopausal women Mijatovic, V.
1996
27 S1 p. 66-
1 p.
artikel
202 F103 Oestradiol implants, patches and reported symptoms Alder, E.M.
1996
27 S1 p. 74-
1 p.
artikel
203 F164 One year results of continuous intrauterine compared to cyclic oral progestin administration in combined HRT in 200 perimenopausal women Boon, J.
1996
27 S1 p. 94-
1 p.
artikel
204 F005 Perceived health among middle-aged women: Networking between individual, environment and society Peltonen, R.S.
1996
27 S1 p. 44-
1 p.
artikel
205 F225 Perimenopausal endometrium: Irregular histologic development Boon, J.
1996
27 S1 p. 113-
1 p.
artikel
206 F151 Pharmacokinetics of a new estradiol matrix patch in healthy postmenopausal volunteers and symptomatic women Müller, P
1996
27 S1 p. 90-
1 p.
artikel
207 F160 Physical activity, climacteric symptoms and bone mass in Hong Kong perimenopausal women Ho, SC
1996
27 S1 p. 93-
1 p.
artikel
208 F030 Physical activity: Preventive of osteoporosis? David, A
1996
27 S1 p. 51-
1 p.
artikel
209 F015 Pilot study of continuous combined post-menopausal HRT using alternate day or twice weekly vaginal progesterone Wardle, P
1996
27 S1 p. 47-
1 p.
artikel
210 F021 Plasma lipids in combined continuous HRT-IUD levonorgestrel VS oral provera Stuckey, BGA
1996
27 S1 p. 49-
1 p.
artikel
211 F190 Plasmatic apolipoproteins and lipidic composition of lipoproteins in pre and postmenopausal women Berg, G
1996
27 S1 p. 103-
1 p.
artikel
212 F172 Postmenopausal hormone replacement therapy increases mammographic breast tissue density van der Mooren, MJ
1996
27 S1 p. 97-
1 p.
artikel
213 F121 Post-menopausal hormone replacement therapy is associated with improved arterial physiology McCrohon, JA
1996
27 S1 p. 80-
1 p.
artikel
214 F198 Postmenopausal symptoms in estrogen treated and non treated women in three age groups Stenberg, A
1996
27 S1 p. 106-
1 p.
artikel
215 F109 Postmenopausal women without vasomotor symptoms have better stress-coping than women with symptoms Nedstrand, EE
1996
27 S1 p. 76-77
2 p.
artikel
216 F157 Postural balance, evaluated by dynamic posturography, is increased by hormone replacement therapy among postmenopausal women Hammar, ML
1996
27 S1 p. 92-
1 p.
artikel
217 F061 Premature menopause: The experience from the woman's perspective Boughton, MA
1996
27 S1 p. 61-
1 p.
artikel
218 F058 Prevalence of osteoporosis in women attending menopause clinic, Chulalongkorn hospital Limpaphavom, K
1996
27 S1 p. 61-
1 p.
artikel
219 F138 Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy (HRT) with 17-β oestradiol (E2) and dydrogesterone Lippuner, K
1996
27 S1 p. 86-
1 p.
artikel
220 F173 Progestin induced apoptosis of normal huma breast cells: An in vivo and in vitro study Desreux, J.
1996
27 S1 p. 97-
1 p.
artikel
221 F027 Prospective comparison of biochemical and radiological markers of bone mineral status in early postmenopausal women O'Herlihy, C.
1996
27 S1 p. 51-
1 p.
artikel
222 F186 Prospective study of bone density following premenopausal hysterectomy Dean, S
1996
27 S1 p. 102-
1 p.
artikel
223 F166 Prospective study of levonorgestrel intrauterine system (LN IUS) as opposition for oestrogen therapy Panay, N.
1996
27 S1 p. 95-
1 p.
artikel
224 F128 Psychological and social concomitants of the female menopause: A longitudinal study Perz, JM
1996
27 S1 p. 82-
1 p.
artikel
225 F042 Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits Bjarnason, NH
1996
27 S1 p. 55-
1 p.
artikel
226 F069 Randomised double-blind dose-ranging study of the endometrial effects of oral trimegestone with 17β oestradiol in postmenopausal women Ross, D
1996
27 S1 p. 64-
1 p.
artikel
227 F177 Randomised double blind placebo controlled crossover study of the effects of hormonin® on cardiac risk factors in hypertensive postmenopausal women Sands, R
1996
27 S1 p. 98-99
2 p.
artikel
228 F113 Randomised, double blind, placebo controlled, cross over study on the effect of 2 MG oestradiol on acute menopausal symptoms in Chinese women Chung, TKH
1996
27 S1 p. 78-
1 p.
artikel
229 F216 Reduction in serum VEGF levels in oophorectomised women treated with transdermal oestrogen Akkad, AA
1996
27 S1 p. 111-
1 p.
artikel
230 F213 Relationship between climacteric symptoms and impaired coronary blood flow, estimated by ECG-triggered magnetic resonance phase mapping Sorensen, MB
1996
27 S1 p. 110-
1 p.
artikel
231 F029 Relationship of serum vitamin K1 and K2 levels to bone mineral density in climacteric women Takagi, T
1996
27 S1 p. 51-
1 p.
artikel
232 F041 Relaxant effects of progesterone and synthetic progestins in rat aorta in comparison to 17β-estradiol Glusa, E
1996
27 S1 p. 55-
1 p.
artikel
233 F059 Risk factors of osteoporosis in Thai women attending menopause clinic at Chulalongkorn hospital Limpaphayom, K
1996
27 S1 p. 61-
1 p.
artikel
234 F205 Role of socio-cultural factors in menopause management Meschia, M
1996
27 S1 p. 107-
1 p.
artikel
235 F102 Route of oestrogen replacement confers distinct and divergent effects on substrate metabolism and body composition in postmenopausal women O'Sullivan, AJ
1996
27 S1 p. 74-
1 p.
artikel
236 F045 Safety study on the action of the vaginal ring estring® on endometrium after a long-term treatment in postmenopausal women Pigné, A.
1996
27 S1 p. 56-
1 p.
artikel
237 F016 Sequential three-monthly versus monthly HRT: A prospective double-blind randomised study van der Mooren, MJ
1996
27 S1 p. 47-
1 p.
artikel
238 F035 Skin thickness measurement for early detection of osteoporosis in menopausal women with transdermal ultrasound Baziad, A
1996
27 S1 p. 53-
1 p.
artikel
239 F232 Sleep disturbances in post-menopausal women Lorrain, Jacques
1996
27 S1 p. 115-
1 p.
artikel
240 F055 Smoking reduces the beneficial effects of continuously combined hormone replacement therapy in reducing bone turnover de Valk-de Roo, G.W.
1996
27 S1 p. 60-
1 p.
artikel
241 F221 Stimulatory effect of percutaneous dehydro-epiandrosterone (DHEA) on bone mineral density in the rat Luo, S.
1996
27 S1 p. 112-
1 p.
artikel
242 F125 Study of the effect of hormone replacement therapy on cardiovascular haemodynamics Hayward, CS
1996
27 S1 p. 81-
1 p.
artikel
243 F227 Summary of combined data on endometrial safety considering the enpoint hyperplasia in postmenopausal women taking sequential, combined estradiol and dydrogesterone (Femoston) Bergeron, C
1996
27 S1 p. 114-
1 p.
artikel
244 F210 Survey of patients attitudes towards attending a menopause clinic Molloy, M.E.
1996
27 S1 p. 109-
1 p.
artikel
245 F145 Sustained-release estradiol implants in HRT: One-year results on hormone levels and menopausal symptoms Suhonen, S.P.
1996
27 S1 p. 88-
1 p.
artikel
246 F212 Systemic hemodynamic changes during unopposed and combined hormone replacement therapy (HRT) Lugones, L
1996
27 S1 p. 110-
1 p.
artikel
247 F046 Targeted drug delivery in gynecology: Vaginal progesterone (P) and the first uterine pass effect Bulletti, C.
1996
27 S1 p. 57-
1 p.
artikel
248 F137 The administration of tibolone: Reduces the untoward effects of GnRH-a: Preliminary results Bontis, J.
1996
27 S1 p. 85-
1 p.
artikel
249 F009 The effect of estrogen replacement therapy on plasma coagulation and fibrinolysis in women with non insulin dependent diabetes mellitus Hahn, L
1996
27 S1 p. 45-
1 p.
artikel
250 F024 The effect of exogenous testosterone on lipid metabolism & insulin resistance in postmenopausal women Sands, R
1996
27 S1 p. 50-
1 p.
artikel
251 F049 The effect of hormone replacement therapy on peripheral blood flow in postmenopausal women Haines, CJ
1996
27 S1 p. 58-
1 p.
artikel
252 F048 The effect of HRT on anorectal function in postmenopausal women with faecal incontinence a preliminary study Donnelly, VS
1996
27 S1 p. 58-
1 p.
artikel
253 F122 The effect of low-dose estrogen treatment on brain blood flow Ohkura, T
1996
27 S1 p. 80-
1 p.
artikel
254 F086 The effect of six years nonbleeding HRT (tibolone) on the female skeleton Rymer, J
1996
27 S1 p. 69-
1 p.
artikel
255 F144 The effect of the dydrogesterone dose in continuously combined HRT regimens on micturition complaints Kok, ALM
1996
27 S1 p. 88-
1 p.
artikel
256 F077 The effect of the menopause on plasma concentrations of lipoprotein(a) Cheung, LP
1996
27 S1 p. 66-
1 p.
artikel
257 F020 The effect of tibolone on serum lipid and lipoprotein levels Ertüngealp, E.
1996
27 S1 p. 49-
1 p.
artikel
258 F214 The effects of acute 2 MG sublingual 17β-estradiol on exercise induced coronary ischemia in older women with coronary artery disease Landgren, BM
1996
27 S1 p. 110-
1 p.
artikel
259 F052 The effects of continuous combined oral oestradiol and norethisterone on pulsatility index in internal carotid artery in previously untreated women Gangar, K.F.
1996
27 S1 p. 59-
1 p.
artikel
260 F051 The effects of continuous combined oral oestradiol and norethisterone on pulsatility index in internal carotid artery in women taking cyclical opposed H.R.T. McCullough, W.
1996
27 S1 p. 58-
1 p.
artikel
261 F053 The effects of progestagens, as part of combined hormone replacement, on vascular tone Luckas, MJ
1996
27 S1 p. 59-
1 p.
artikel
262 F132 The effects of short-term ERT on cognitive performance in naturally postmenopausal women Woodruff, WJ
1996
27 S1 p. 84-
1 p.
artikel
263 F089 The effects of surgical menopause and parenteral hormone replacement therapy on bone density, menopausal symptoms and hormone profiles Anderson, CHM
1996
27 S1 p. 70-
1 p.
artikel
264 F062 The impact of androgen levels on bone density in patients with premature ovarian failure Albrecht, AE
1996
27 S1 p. 62-
1 p.
artikel
265 F206 The impact of hormone replacement therapy on quality of life and willingness to pay Strand, RT
1996
27 S1 p. 108-
1 p.
artikel
266 F039 The influence of acute and chronic exposure to 17-β-estradiol on the arterial contractility in rat thoracic aorta Andersen, HL
1996
27 S1 p. 54-
1 p.
artikel
267 F054 The influence of autonomic imbalance on the symptoms due to blood flow disorder Aso, K
1996
27 S1 p. 59-
1 p.
artikel
268 F219 The influence of dietary calcium intake on lumbar bone mineral density under estrogen/gestagen and/or viatmin D3 treatment Iwaoki, Y
1996
27 S1 p. 112-
1 p.
artikel
269 F012 The influence of different progestin doses on coagulation parameters in women receiving hormone replacement therapy Straube, W
1996
27 S1 p. 46-
1 p.
artikel
270 F188 The influence of hormone replacement with conjugated equine estrogen or with estradiol on lipid metabolism in postmenopausal women Nakagawa, T
1996
27 S1 p. 102-
1 p.
artikel
271 F178 The influence of long-term HRT treatment on ambulatory bloodpressure in older women with coronary artery disease Pripp, UM
1996
27 S1 p. 99-
1 p.
artikel
272 F174 The influence of menstrual cycle phase on proliferation of breast epithelial cells in vivo Söderqvist, G
1996
27 S1 p. 97-
1 p.
artikel
273 F118 The influence of MPA treatment in HRT on vascular smooth muscle cells Okubo, T
1996
27 S1 p. 79-
1 p.
artikel
274 F100 the influence of postmenopausal hormone replacement therapy on body composition Hänggi, W
1996
27 S1 p. 73-
1 p.
artikel
275 F179 The influence of postmenopausal oestradiol-dydrogesterone therapy on blood pressure van der Mooren, MJ
1996
27 S1 p. 99-100
2 p.
artikel
276 F082 The leicester endometrial needle sampler (lens) in the postmenopausal patient: A novel outpatient hysteroscopy-directed biopsy Habiba, MA
1996
27 S1 p. 68-
1 p.
artikel
277 F201 The menopausal transition and cardiovascular risk factors Green, A
1996
27 S1 p. 106-
1 p.
artikel
278 F071 The occurrence of different endometrial histological findings in perimenopausal symptomatic women Carones, M Barbieri
1996
27 S1 p. 64-
1 p.
artikel
279 F025 The prevalence of osteopenia and osteoporosis according to who criteria, in women in their seventh decade and the sensitivity and specificity of bone densitometry referral criteria Ballard, P.A.
1996
27 S1 p. 50-
1 p.
artikel
280 F004 The relative contribution of change in paid work status to change in health outcomes in midlife Dennerstein, L
1996
27 S1 p. 44-
1 p.
artikel
281 F026 The relative contributions of aging and menopause in determining involutional osteopenia Gambacciani, M
1996
27 S1 p. 50-
1 p.
artikel
282 F185 The risk of myocardial infarction after oophorectomy and hysterectomy Falkeborn, M
1996
27 S1 p. 101-
1 p.
artikel
283 F167 The use of a levonorgestral-intrauterine device in reduction of withdrawal bleeding in menopausal women with uterine fibroids Singer, A.
1996
27 S1 p. 95-
1 p.
artikel
284 F143 The use of two estrogen preparations (A combined contraceptive pill V.S. conjugated estrogen cream) intravaginally to treat urogenital symptoms in thai post-menopausal women: A comparative study Chompootaweep, S
1996
27 S1 p. 87-88
2 p.
artikel
285 F140 The vaginal echo system in menopause and influence of hormonal replacement therapy Platz-Christensen, JJ
1996
27 S1 p. 86-87
2 p.
artikel
286 F095 the vasorelaxant effect of a series of estrogenic agonists and partial agonists is not correlated to their affinity at the estrogen receptor Sheardown, MJ
1996
27 S1 p. 72-
1 p.
artikel
287 F010 Tibolone: Effects on cardiovascular risk factors: Lipid and haemostasis Bjarnason, NH
1996
27 S1 p. 45-
1 p.
artikel
288 F224 Tibolone in climacterium: effect on the uterine endometrium of postmenopausal women Klearchou, N.
1996
27 S1 p. 113-
1 p.
artikel
289 F152 Tolerability and adhesion characteristics of a new matrix patch (Estraderm MX 50) Cioppa, G Delia
1996
27 S1 p. 90-
1 p.
artikel
290 F013 Transdermal continuous oestrogen and interrupted progestogen as a novel ‘bleed-free’ regime of HRT for postmenopausal women Cameron, S.T.
1996
27 S1 p. 46-
1 p.
artikel
291 F074 Transdermal oestradiol lowers cholesterol in moderately hypercholesterolemic women Göran, Samsioe
1996
27 S1 p. 65-66
2 p.
artikel
292 F189 Transdermal or oral 17β-estradiol on plasma lipid profiles; a controlled study Berg, G
1996
27 S1 p. 103-
1 p.
artikel
293 F081 Transvaginal sonography and endometrial histopathology in postmenopausal women treated with hormonal replacement therapy Lindgren, R
1996
27 S1 p. 68-
1 p.
artikel
294 F182 Treatment of recurrent bleeding disorders during hormone replacement therapy by transcervical endometrial ablation Römer, T
1996
27 S1 p. 100-
1 p.
artikel
295 F072 Ultrasound morphometric assessment of the endometrium in symptomatic postmenopausal women Miragoli, A
1996
27 S1 p. 65-
1 p.
artikel
296 F043 Urogenital atrophy: Need for standardized assessment of outcomes-a rut committee report Bachmann, G.
1996
27 S1 p. 56-
1 p.
artikel
297 F142 Vagifem vs premarin® vaginal cream — A comparative evaluation Devlin, C
1996
27 S1 p. 87-
1 p.
artikel
298 F047 Vaginal progesterone (P) in menopause: Long term acceptability of a new therapeutic option for physiological progesterone replacement Jääskeläinen, A.
1996
27 S1 p. 57-
1 p.
artikel
299 F067 Women's opinion about the re-occurrence of vaginal bleeds before their start with a sequential HRT regimen for the prevention of osteoporosis van de Weijer, PHM
1996
27 S1 p. 63-
1 p.
artikel
300 F134 3 Years prevention of postmenopausal bone loss: Conjugated estrogen-medroxyprogesterone vs tibolone Thiébaud, D.
1996
27 S1 p. 84-
1 p.
artikel
301 57 Hormones and heart disease and women Barrett-Connor, Elizabeth
1996
27 S1 p. 41-
1 p.
artikel
302 P191a Breast response to hormonal replacement therapy (HRT) in pre- and post-menopausal women with concomitant benign breast disease (BBD) Cupceancu, B
1996
27 S1 p. 177-
1 p.
artikel
303 P150 Ace inhibitor vs. calcium-antagonist in postmenopausal women: Results from the madam-program Prüsse, DI
1996
27 S1 p. 163-
1 p.
artikel
304 P004 A clinical trial on the effects of a combination of estrogens and Vit. D3 on bone loss in pre-and post-menopausal women Tamura, I
1996
27 S1 p. 117-
1 p.
artikel
305 P284 A comparative study of progesterone (P) pharmacokinetics following administration of crinone® and utrogestan® (UT) to healthy postmenopausal women Levine, HL
1996
27 S1 p. 204-205
2 p.
artikel
306 P079 A comparative study of the effect of kliogest and livial on carbohydrate metabolism in post-menopausal women Joyce, M.
1996
27 S1 p. 140-
1 p.
artikel
307 P225 A comparison of bleeding patterns with prempack C and transdermal estradiol and norethisterone acetate (Estracombi) Parsons Rugby, AD
1996
27 S1 p. 187-
1 p.
artikel
308 P262 A comparison of self-rated and menstrually derived menopausal status Garamszegi, CV
1996
27 S1 p. 198-
1 p.
artikel
309 P075 A comparison of the levels of immunoreactive inhibin and dimeric inhibin a in perimenopausal women Burger, HG
1996
27 S1 p. 138-139
2 p.
artikel
310 P253 Activation of dormant abdominal wall endometriosis by hormone replacement therapy Hackman, B.W.
1996
27 S1 p. 195-
1 p.
artikel
311 P294 A 25% difference in E2 concentrations contained in a matrix-type patch, does not affect the daily E2 release Rocher, I
1996
27 S1 p. 208-
1 p.
artikel
312 P267 A double-blind, placebo-controlled crossover study to determine the effects of a new 17B oestradiol transdermal matrix patch on climacteric symptoms in hysterectomised postmenopausal women Cooper, A
1996
27 S1 p. 199-
1 p.
artikel
313 P330 Age at menopause: The effect of leimyoma uteri Gökmen, O.
1996
27 S1 p. 218-
1 p.
artikel
314 P067 Ageing, menopausal therapy and kidney function Ginsburg, Jean
1996
27 S1 p. 136-
1 p.
artikel
315 P193 A menopause oncology clinic: A novel service Rees, MCP
1996
27 S1 p. 177-
1 p.
artikel
316 P043 An epidemiologic study of the bone mineral status of Turkish women Möröy, P.
1996
27 S1 p. 128-
1 p.
artikel
317 P135 A new model for induction of intimal hyperplasia in human blood vessels using postmenopausal serum Al-Azzawi, F
1996
27 S1 p. 159-
1 p.
artikel
318 P287 A new second generation transdermal drug delivery system for HRT: Mechanism of action Rohr, U.D.
1996
27 S1 p. 205-
1 p.
artikel
319 P298 An open, randomized assessment of the efficacy and safety of two transdermal estradiol patches for relief of climacteric symptoms Baracat, E
1996
27 S1 p. 209-
1 p.
artikel
320 P140 An open study of the effects of oral 17B oestradiol and oral dydrogesterone on the internal carotid artery pulsatility index in hysterectomised women Cooper, A
1996
27 S1 p. 160-
1 p.
artikel
321 P070 Anthropometric measurement by means of dual-energy-X-ray absorptiometry in menopausal women Gruber, DM
1996
27 S1 p. 137-
1 p.
artikel
322 P133 Antihypertensive treatment in postmenopausal women: Diuretic or ace inhibitor? Stimpel, M
1996
27 S1 p. 158-
1 p.
artikel
323 P291 A retrospective assessment of sixteen years experience with oestrogel in three specialist menopause clinics Colville, NJ
1996
27 S1 p. 207-
1 p.
artikel
324 P335 Assessing post menopausal status after hysterectomy Everett, MP
1996
27 S1 p. 220-
1 p.
artikel
325 P221 Assessment of endometrial histology in women on tamoxifen therapy by ultrasonography Moskovic, T
1996
27 S1 p. 186-
1 p.
artikel
326 P210 Associated factors to urinary and genital symptoms prevalence in climateric and postmenopausal women Guarisi, T
1996
27 S1 p. 182-
1 p.
artikel
327 P061 Association of the ß3-adrenergic receptor gene TRP64ARG mutation with weight, body mass index, abdominal fat, blood pressure and reproduction Kurabayashi, T
1996
27 S1 p. 135-
1 p.
artikel
328 P288 A study of the effect of transdermal opposed HRT therapy (femapak 80) on flushing, endometrium and lipid profile Cogswell, D
1996
27 S1 p. 206-
1 p.
artikel
329 P268 A study on premenopausal symptoms of Turkish women Oransay, S.
1996
27 S1 p. 200-
1 p.
artikel
330 P113a The influence of long-term HRT on ambulatory bloodpressure in older women with coronary artery disease Pripp, UM
1996
27 S1 p. 152-
1 p.
artikel
331 P148 Atherogenic risk: Effects of combined continuous oestradiol-medroxyprogesterone administration on plasma lipids, lipoproteins and coagulation profiles Vidal, D. Rodriguez
1996
27 S1 p. 163-
1 p.
artikel
332 P307 A two-vear study with low dose, continuous, unopposed esterified estrogens: Prevention of postmenopausal bone loss with minimal endometrial effects Lucas, J.
1996
27 S1 p. 212-
1 p.
artikel
333 P055 Audit of general practitioner (GP) referrals to hospital based menopause clinic Sethi, K.K.
1996
27 S1 p. 132-
1 p.
artikel
334 P099 Background of aging change in arterial wall: Intimal hyperplasia with the impaired synergism between PG12 and nitric oxide in human uterine arteries before menopause Obayashi, S
1996
27 S1 p. 147-
1 p.
artikel
335 P169 Beneficial changes in lipoproteins and plasma renin activity during lyrelle 17β-E2 patch (25 cm2 and 40 cm2) and estraderm TTS®50 in hysterectomised postmenopausal women van der Mooren, MJ
1996
27 S1 p. 169-
1 p.
artikel
336 P189 Beneficial effects of hormone replacement therapy: Testosterone in hypogonadal men and estrogen in postmenopausal women on plasma IGF-I, lipids and lipoproteins concentrations Zgliczynski, S.
1996
27 S1 p. 176-
1 p.
artikel
337 P090 Biovailability of percutaneously administered dehydroepiandrosterone in the rat Labrie, C.
1996
27 S1 p. 143-
1 p.
artikel
338 P241 Bleeding pattern in two combined continuous hormone replacement therapy (HRT) regimes in climacteric women Campodónico, I
1996
27 S1 p. 191-
1 p.
artikel
339 P247 Bleeding rates-during a long-term placebo-controlled study with two doses of tibolone Berning, B
1996
27 S1 p. 193-
1 p.
artikel
340 P138 Bodycomposition in postmenopausal women correlates with cardiovascular parameters estimated by ECG-triggered magnetic resonance phase mapping Sorensen, MB
1996
27 S1 p. 159-
1 p.
artikel
341 P034 Bone mass density and mechanical properties of forearms of women in peri and postmenopausal period affected by Colles fractures Bienkowska, R.
1996
27 S1 p. 126-
1 p.
artikel
342 P002 Bone mass is increased by tibolone in postmenopausal women with previous fractures Studd, J
1996
27 S1 p. 117-
1 p.
artikel
343 P042 Bone mineral content of postmenopausal women with leiomyoma uteri Möröy, P.
1996
27 S1 p. 128-
1 p.
artikel
344 P035 Bone mineral density in postpartum women Honda, A
1996
27 S1 p. 126-
1 p.
artikel
345 P023 Bone mineral density in spontaneous and surgically postmenopausal women receiving hormonal replacement therapy Castelo-Branco, C.
1996
27 S1 p. 123-
1 p.
artikel
346 P037 Bone mineral density levels and T-young score (SD) related to femur fracture in a group of postmenopausal women Russo, L.A.
1996
27 S1 p. 127-
1 p.
artikel
347 P194 Breast and thyroid disease screening for perimenopausal woman by ultrasound Hachiva, T
1996
27 S1 p. 178-
1 p.
artikel
348 P191 Breast cancer in postmenopausal women: General profile of the patient in our region (Madrid) Nieto, A
1996
27 S1 p. 177-
1 p.
artikel
349 P195 Breast self-examination: Knowledge and performance among women attending menopause clinic Poomarporn, Orn-Anong
1996
27 S1 p. 178-
1 p.
artikel
350 P196 Breast self-examination technique among women attending menopause clinic Khanacharoen, Adchara
1996
27 S1 p. 178-
1 p.
artikel
351 P117 Cardiovascular risk factors and BMD changes during micronized 17βestradiol and dydrogesterone oral therapy in postmenopausal women: A three-year prospective study Palacios, S
1996
27 S1 p. 153-
1 p.
artikel
352 P149 Cardiovascular risk factors, bleeding patterns and endometrial histology in postmenopausal women taking sequential combined estradiol and dydrogesterone (Femoston), results from a one-year study Gelfand, MM
1996
27 S1 p. 89-
1 p.
artikel
353 P120 Carotid artery wall correlates with skin thickness in postmenopausal women Baron, Y. Muscat
1996
27 S1 p. 154-
1 p.
artikel
354 P121 Carotid artery wall thickness in postmenopausal women treated with hormone replacement therapy Baron, Y. Muscat
1996
27 S1 p. 154-
1 p.
artikel
355 P325 Case report: Monozygotic twin, one of which was anencephalic in a climacteric patient Jeri, AR
1996
27 S1 p. 217-
1 p.
artikel
356 P005 Changes in bone collagen markers in untreated oestrogen treated postmenopausal women Brincat, M.P.
1996
27 S1 p. 118-
1 p.
artikel
357 P168 Changes in the cardiovascular risk profile of postmenopausal women on three-monthly HRT van der Mooren, MJ
1996
27 S1 p. 169-
1 p.
artikel
358 P006 Changes of bone metabolism and bone density in ovarectomized women in fertile age treated with estradiol valerate and levonorgestrel Zivný, J
1996
27 S1 p. 118-
1 p.
artikel
359 P316 Chinese herbal medicine-a treatment for perimenopausal hot flushes? Beer, S.L.
1996
27 S1 p. 214-
1 p.
artikel
360 P048 Classification of lumbar vertebral type based on bone mineral density and its clinical significance Watanabe, R
1996
27 S1 p. 130-
1 p.
artikel
361 P265 Climacteric symptoms and nutritional status in Japanese women Sugiyama, M.
1996
27 S1 p. 199-
1 p.
artikel
362 P263 Climacteric symptoms in a postmenopausal czech population Nedstrand, EE
1996
27 S1 p. 198-
1 p.
artikel
363 P321 Climacterium virile-influenced in pesticide applicators Straube, E
1996
27 S1 p. 216-
1 p.
artikel
364 P203 Clinical and cytovaginal effects of oestriol intravaginally in postmenopausal women with urogenital complaints Lutan, D
1996
27 S1 p. 180-
1 p.
artikel
365 P020 Clinical and metabolic aspects of post-menopausal women treated with tibolone Wehba, S
1996
27 S1 p. 122-
1 p.
artikel
366 P167 Clinical and psychometric studies in menopausal syndrome patients with and without depression Brandstätter, N
1996
27 S1 p. 168-
1 p.
artikel
367 P270 Clinical efficacy of percutaneous ERT and HRT in postmenopausal women Boschitsch, E
1996
27 S1 p. 200-
1 p.
artikel
368 P216 Clinical-epidemiological characteristics of two postmenopausal populations with different social-economical and educational levels Krakover, R
1996
27 S1 p. 184-
1 p.
artikel
369 P319 Clinical evaluation of non-hormonal drug ‘Minofil’ in the management of post menopausal syndrome Nanda, U.K.
1996
27 S1 p. 215-
1 p.
artikel
370 P266 Clinical experience with tibolone (livial) Theppisai, U.
1996
27 S1 p. 199-
1 p.
artikel
371 P286 Clinical, lipoprotein and mamographic changes in climacteric women treated with two combined continuous (CC) hormone replacement therapy (HRT) regimes Valdivia, I
1996
27 S1 p. 205-
1 p.
artikel
372 P276 Clinical results of EP and P therapy in premenopausal women Marianowski, L.
1996
27 S1 p. 202-
1 p.
artikel
373 P207 Clinical trial of vaginally administered conjugated estrogens and tibolone in postmenopausal women Botsis, D.
1996
27 S1 p. 181-
1 p.
artikel
374 P132 Coadministration of moexipril and hormonal replacement therapy in postmenopausal women Stimpel, M
1996
27 S1 p. 157-
1 p.
artikel
375 P116 Coagulation and fibrinolysis in postmenopausal women during hormonal replacement therapy (transdermal estradiol/medroxyprogesterone acetate oraly) Ciepluch, R.
1996
27 S1 p. 153-
1 p.
artikel
376 P248 Combined continuous hormonal replacement therapy (CC-HRT) influence of progestagen doses (PD) on bleeding (B) patterns of postmenopausal women (PW) Rodriguez Vidal, D
1996
27 S1 p. 193-194
2 p.
artikel
377 P069 Comparative assessment of endocrinologic stimulation tests (TRH; GH-RH) with patients at fertile age and climacteric patients Jirecek, SG
1996
27 S1 p. 137-
1 p.
artikel
378 P134 Comparison between moexipril and atenolol in obese postmenopausal women with hypertension Stimpel, M
1996
27 S1 p. 158-
1 p.
artikel
379 P018 Comparison of bone mineral density changes of a transdermally administrated 17β-estradiol combined with different progestagens. A case-control study Pornel, B
1996
27 S1 p. 121-
1 p.
artikel
380 P243 Comparison of endometrial evaluation by transvaginal ultrasonography (TVU) and endometrial biopsy in postmenopausal women Lopes, P.
1996
27 S1 p. 192-
1 p.
artikel
381 P199 Comparison of mamographic findings in asymptomatic patients and cases with breast symptoms Gülerman, C.
1996
27 S1 p. 179-
1 p.
artikel
382 P009 Comparison of the effect of divigel, a percutaneous estradiol gel and estraderm (TTS) treatment on total body bone mineral density and lipid metabolism in menopause Kivinen, S
1996
27 S1 p. 119-
1 p.
artikel
383 P153 Comparison of the effects of oral and transdermal HRT on plasma endothelin-1 and urinary excretion of prostacyclin and throm☐ane metabolites Ylikorkala, O
1996
27 S1 p. 164-
1 p.
artikel
384 P338 Compliance to estrogen treatment after hysterectomy and bilateral oophorectomy, patients lifestyle and knowledge of HRT effects Hée, P
1996
27 S1 p. 220-
1 p.
artikel
385 P060 Compliance with hormone replacement therapy in women attending a menopause clinic Molloy, ME
1996
27 S1 p. 134-
1 p.
artikel
386 P130 Compliance with HRT in postmenopausal women with coronary artery disease Hall, G
1996
27 S1 p. 157-
1 p.
artikel
387 P027 Concentrations of procollagen type I C-peptide and Gla-osteocalcin in normal and osteoporetic women during hormone replacement therapy Klinga, K
1996
27 S1 p. 124-
1 p.
artikel
388 P010 Conjugated estrogen at a daily dose of 0.625 MG and 0.3 MG had almost the same impact on the changes of bone mineral density and bone metabolism in postmenopausal women Chen, J.T.
1996
27 S1 p. 119-
1 p.
artikel
389 P146 Continuous treatment with estradiol and norethisterone actetate and the influence on risk factors for cardiovascular disease Moen, MH
1996
27 S1 p. 162-
1 p.
artikel
390 P044 Correlation between mineral density of each lumbar vertebral bone and age in pre- and postmenopausal women Ishikawa, K.
1996
27 S1 p. 129-
1 p.
artikel
391 P158 Current opinion about psychological and psychosocial aspects using health questionnaires to maintenance HRT compliance Frailuna, JP
1996
27 S1 p. 165-166
2 p.
artikel
392 P112 Dermatological changes associated with hormonal environment in perimenopausal Japanese women Makita, K
1996
27 S1 p. 151-
1 p.
artikel
393 P028 Determination of bone resorption in postmenopausal women by four bio-markers at urine Gulbaba, RG
1996
27 S1 p. 125-
1 p.
artikel
394 P231 Diagnostic assessment of postmenopausal uterine bleeding by outpatient hysteroscopy and endometrial sampling Benfatti, M
1996
27 S1 p. 189-
1 p.
artikel
395 P293 Differences in lipids and bleeding patterns between 2 types of hormonal replacement therapy = a sequential versus a continuous combined hormonal replacement Yu, SL
1996
27 S1 p. 207-
1 p.
artikel
396 P101 Direct atheroprotective effect of estrogen on human smooth muscle cells and endothelial cells Urabe, M.
1996
27 S1 p. 147-
1 p.
artikel
397 P326 Disease risks for long term users of hormone replacement therapy Geelhoed, EA
1996
27 S1 p. 217-
1 p.
artikel
398 P142 Diurnal variation in uterine artery pulsatility index in postmenopausal women using transdermal oestradiol Ross, D
1996
27 S1 p. 161-
1 p.
artikel
399 P025 Does HRT in pre-menopausal women improve bone density and bone turnover markers Orr, M
1996
27 S1 p. 123-
1 p.
artikel
400 P040 Does low bone mineral density in anorexia nervosa depend on secondary amenorrhea duration? Krzyzanowska, B
1996
27 S1 p. 128-
1 p.
artikel
401 P206 Does smoking induce vaginal maturity? Nilsson, K.E.
1996
27 S1 p. 181-
1 p.
artikel
402 P163 Effect of estrogen on senile dementiaAlzheimer's type through suppression of apolipoprotein E Iwasa, K
1996
27 S1 p. 167-
1 p.
artikel
403 P285 Effect of estrogen replacement on functioning ovaries after hysterectomy Eicher, W
1996
27 S1 p. 205-
1 p.
artikel
404 P008 Effect of hormonal replacement therapy (HRT) by oral or transdermal route in the maintenance of bone density in postmenopausal women Guinot, M.
1996
27 S1 p. 118-
1 p.
artikel
405 P007 Effect of medrogestone in the maintenance of bone density of surgically-menopausic women using oral and transdermal-estrogen substitutive therapy Guinot, M
1996
27 S1 p. 118-
1 p.
artikel
406 P176 Effect of medrogestone over lipid pattern of surgically-menopausic women on oral- and transdermal-estrogen sustitutive therapy Guinot, M
1996
27 S1 p. 171-172
2 p.
artikel
407 P011 Effect of 12-month DHEA replacement therapy on bone mineral density in 60-to 70-year-old women Labrie, F
1996
27 S1 p. 119-
1 p.
artikel
408 P185 Effect of progestogens on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens Takada, S
1996
27 S1 p. 175-
1 p.
artikel
409 P204 Effect of replens-a nonhormonal vaginal moisturizer on vaginal atrophy in breast cancer patients: A cytological study Ragavan, V.V.
1996
27 S1 p. 180-
1 p.
artikel
410 P314 Effect of supplemental isoflavones on noninvasive haemodynamics in postmenopausal women Hayward, CS
1996
27 S1 p. 214-
1 p.
artikel
411 P166 Effect on sexual life-a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen Nathorst-Böös, J
1996
27 S1 p. 168-
1 p.
artikel
412 P310 Effects of apoe phenotype on lipids, fat rates and climacteric symptoms Somekawa, Y
1996
27 S1 p. 213-
1 p.
artikel
413 P144 Effects of continuous combined estrogen and progestogen replacement therapy on the uterine vasculatur tree of postmenopausal women Dören, M
1996
27 S1 p. 161-
1 p.
artikel
414 P222 Effects of cyproterone acetate and medroxyprogesterone acetate on endometrial levels of IGF-IR and IGFBP-I in endometrial hyperplasia Baysal, B
1996
27 S1 p. 186-
1 p.
artikel
415 P315 Effects of dietary phytoestrogens in postmenopausal women Dalais, FS
1996
27 S1 p. 214-
1 p.
artikel
416 P179 Effects of hormone replacement therapy on lipoprotein (a) and other lipids Meschia, M.
1996
27 S1 p. 173-
1 p.
artikel
417 P127 Effects of hormone replacement therapy on pulse wave velocity in postmenopausal women Nakagawa, H
1996
27 S1 p. 156-
1 p.
artikel
418 P173 Effects of hormone replacement therapy on remnant lipoproteins in menopausal women Sanada, M
1996
27 S1 p. 171-
1 p.
artikel
419 P108 Effects of HRT in the early menopause Bris, J.M.
1996
27 S1 p. 149-
1 p.
artikel
420 P124 Effects of low-dose HRT on arterial elasticity and flow-mediated endothelium-(in)dependent vasodilation in postmenopausal women van Baal, W.M.
1996
27 S1 p. 155-
1 p.
artikel
421 P178 Effects of medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen Wakatsuki, A
1996
27 S1 p. 172-
1 p.
artikel
422 P068 Effects of tibolone on diabetic control and serum lipids in postmenopausal women with non-insulin dependent diabetes mellitus Prelevic, Gordana M
1996
27 S1 p. 137-
1 p.
artikel
423 P257 Effects of tibolone on endometrium and vagina in post menopausal women Wehba, S
1996
27 S1 p. 196-
1 p.
artikel
424 P256 Effects of tibolone on evolution of uterine fibroids in post menopausal women Wehba, S
1996
27 S1 p. 196-
1 p.
artikel
425 P165 Effects of tibolone on sexuality in postmenopausal women Wehba, S
1996
27 S1 p. 168-
1 p.
artikel
426 P017 Effects on lipids and bone of 20 years postmenopausal HRT with the synthetic oestrogen, mestranol, followed by 2 years with oestradiol Farish, E
1996
27 S1 p. 121-
1 p.
artikel
427 P111 Efficacy and skin irritation with two forms of transdermal estrogen therapy Bäckström, A-C
1996
27 S1 p. 151-
1 p.
artikel
428 P296 Efficacy and tolerability of the 7-day transdermal estradiol patch S21102 in the treatment of postmenopausal symptoms Pelissier, C
1996
27 S1 p. 208-
1 p.
artikel
429 P275 Efficacy and tolerability of two sizes of lyrelle 17ßE2 Patch (25 cm2 and 40 cm2) compared with estraderm TTS®50 in hysterectomised postmenopausal women van der Mooren, MJ
1996
27 S1 p. 202-
1 p.
artikel
430 P300 Efficacy of tibolone during early menopause and postmenopause Lugones, L
1996
27 S1 p. 210-
1 p.
artikel
431 P254 Endometrial assessment of patients in menopause clinic Gökmen, O.
1996
27 S1 p. 195-
1 p.
artikel
432 P226 Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: A transvaginal ultrasound study Fallo, L.
1996
27 S1 p. 187-
1 p.
artikel
433 P223 Endometrial effects during long-term hormonal replacement therapy Spiewankiewicz, Beata
1996
27 S1 p. 186-
1 p.
artikel
434 P259 Endometrial histology and bleeding pattern during continuous HRT for one year Wollter-Svensson, L-O
1996
27 S1 p. 196-
1 p.
artikel
435 P235 Endometrial histology and the bleeding pattern of postmenopausal women on continuous combined HRT compared to tibolone Al-Azzawi, F
1996
27 S1 p. 190-
1 p.
artikel
436 P236 Endometrial responses to a hormone replacement therapy (HRT) regimen: Comparative histopathological assessment during the late “pseudo-luteal” phase Habiba, MA
1996
27 S1 p. 190-
1 p.
artikel
437 P258 Endometrial safety during the sequential hormone replacement therapy Zaidieva, Ya.Z.
1996
27 S1 p. 196-
1 p.
artikel
438 P227 Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) Omodel, U.
1996
27 S1 p. 188-
1 p.
artikel
439 P220 Endometrium evaluation by microhysteroscopy study in climateric patients and its correlation by ultrasound study method Dotto, JE
1996
27 S1 p. 186-
1 p.
artikel
440 P237 Enhanced proliferation of endometrial stromal leukocytes during the late pseudoluteal phase of a hormone replacement therapy (HRT) regimen Habiba, MA
1996
27 S1 p. 190-
1 p.
artikel
441 P322 Estradiol-17α — A reasonable hormone replacement for the aging male? Schröder, J
1996
27 S1 p. 216-
1 p.
artikel
442 P103 Estradiol inhibits the voltage-dependent Ca channels of the rabbit basilar artery through GTP-binding protein Ogata, R
1996
27 S1 p. 148-
1 p.
artikel
443 P063 Estradiol or tibolone administration increases GH secretion in postmenopausal women Genazzani, AD
1996
27 S1 p. 135-
1 p.
artikel
444 P104 Estradiol relaxes the rabbit basilar artery through voltage-dependent Ca channels Hashimoto, K
1996
27 S1 p. 148-
1 p.
artikel
445 P100 Estrogen effect on expression of mRNA of PDGF-α, IL-1 and IL-6 in human umbilical venous endothelial cells Tsuchiya, H
1996
27 S1 p. 147-
1 p.
artikel
446 P021 Evaluation of bone turnover biochemical markers and bone density during treatment of postmenopausal osteoporosis with transdermal estrogen Kaminski, K.
1996
27 S1 p. 122-
1 p.
artikel
447 P022 Evolution of the effect of hormonal replacement therapy in bone mineral density in postmenopausal women Castelo-Branco, C.
1996
27 S1 p. 122-
1 p.
artikel
448 P283 Experiences with a new sequential hormone replacement therapy in perimenopausal women Ernst, U
1996
27 S1 p. 204-
1 p.
artikel
449 P318 Extract of cimicifuga racemosa in the treatment of neurovegetative symptoms in women in the perimenopausal period Mielnik, Jetzy
1996
27 S1 p. 215-
1 p.
artikel
450 P301 Five year experience with hormone replacement therapy Magyar, Z
1996
27 S1 p. 210-
1 p.
artikel
451 P065 Five years therapy of HRT and the effect on body mass index Rymer, J
1996
27 S1 p. 136-
1 p.
artikel
452 P197 Fluid in the uterine cavity in postmenopausal women-the sign of endometrial carcinoma? Surkont, G
1996
27 S1 p. 178-
1 p.
artikel
453 P114 Haemostatic risk factors in postmenopausal women (PostMW) and their vascular implications Vilarin˜o, A.
1996
27 S1 p. 152-
1 p.
artikel
454 P228 Histopathological findings of endometria on peri-menopausal uterine bleedings Kagabu, T.
1996
27 S1 p. 188-
1 p.
artikel
455 P299 Hormonal replacement therapy (HRT) evaluation of a novel 25 days regimen with percutaneous estradiol(PE2) and micronized oral progesterone(MP) Marengo, M
1996
27 S1 p. 209-
1 p.
artikel
456 P264 Hormonal replacement therapy in postmenopausal ovarian insufficiency Allamazyan, E.K.
1996
27 S1 p. 199-
1 p.
artikel
457 P050 Hormone replacement therapy (HRT): A comparison of informed decision making and patient satisfaction in a traditional office visit versus a group visit Blomo, CS
1996
27 S1 p. 131-
1 p.
artikel
458 P119 HRT decreases coronary artery calcification Shemesh, J
1996
27 S1 p. 154-
1 p.
artikel
459 P026 HRT does not obtain bone metabolism response in each and every case Ohta, H
1996
27 S1 p. 123-
1 p.
artikel
460 P064 HRT in renal transplant recipients evaluation of effectiveness and safety-preliminary data Pietrzak, B.
1996
27 S1 p. 135-
1 p.
artikel
461 P238 Hysteroscopic assessment: Value in predicting abnormal uterine bleeding in perimenopausal women and bleeding on HRT Habiba, MA
1996
27 S1 p. 191-
1 p.
artikel
462 P336 Hysteroscopic resection of benign intrauterine lesions in post-menopausal women Grassini, E
1996
27 S1 p. 220-
1 p.
artikel
463 P136 ICAM-1 expression in human blood vessels cultured in postmenopausal serum Akkad, AA
1996
27 S1 p. 159-
1 p.
artikel
464 P180 Impact of combined hormone replacement therapy (HRT) on serum low density lipoprotein (LDL) particle size Alexandersen, P.
1996
27 S1 p. 173-
1 p.
artikel
465 P122 Impaired ovarian function as a risk factor for atherosclerosis in premenopausal women Punnonen, RH
1996
27 S1 p. 154-
1 p.
artikel
466 P230 Incidence of breakthrough bleeding after changing from cyclical HRT to tibolone Ahmed, AIH
1996
27 S1 p. 188-189
2 p.
artikel
467 P096 Influence of oestrogen-only hormone replacement therapy on blood angiotensin I-converting enzyme activity Proudler, AJ
1996
27 S1 p. 146-
1 p.
artikel
468 P139 Influence of oral gestagen on the effect of transdermal estrogen replacement therapy (ERT) on endothelial dysfunction in postmenopausal women Haller, H.
1996
27 S1 p. 160-
1 p.
artikel
469 P183 Influence on lipoprotein and bone metabolism of megestrol acetate, used in the management of symptomatic postmenopausal women Farish, E
1996
27 S1 p. 174-
1 p.
artikel
470 P082 Inhibin B concentrations in the menopausal transition Illingworth, PJ
1996
27 S1 p. 140-141
2 p.
artikel
471 P015 Integrated management of postmenopausal osteoporosis in a regional centre in hungary Balogh, A
1996
27 S1 p. 120-
1 p.
artikel
472 P242 Interest of transvaginal color doppler ultrasonography (TCDU) in postmenopausal women prior hormone replacement therapy (HRT) Zenatti, M.
1996
27 S1 p. 192-
1 p.
artikel
473 P172 In vitro effect of estradiol(E2), progesterone (P) and testosterone (T) on LDL-cholesterol oxidation in postmenopausal women Arteaga, E
1996
27 S1 p. 170-
1 p.
artikel
474 P089 In vitro investigations on the calcium-blocking effect of estrogens and progestogens Mueck, AO
1996
27 S1 p. 143-
1 p.
artikel
475 P129 Is the arterial wall composition preserved by estrogens? A comparative study between long-term users, age matched controls and young women Naessén, T
1996
27 S1 p. 156-
1 p.
artikel
476 P217 Knowledge, attitude and practice of obstetrician and gynecologists in Taiwan towards menopause Yao, B.L.
1996
27 S1 p. 184-
1 p.
artikel
477 P201 Laparoscopic colpourethrocystopexi in postmenopausal women Al-Hijii, J
1996
27 S1 p. 180-
1 p.
artikel
478 P095 Levormeloxifene, a non-steroidal estrogen receptor therapeutic, exerts a non-proliferative action on uterine tissues of the ovariectomized rat Korsqaard, N.
1996
27 S1 p. 145-
1 p.
artikel
479 P094 Levormeloxifene, a non-steroidal estrogen receptor therapeutic, mimics estrogen effects on expression of tartrate resistant acid phosphatase, carbonic anhydrase-II, and estrogen receptor in ovariectomized rats Wassermann, K.
1996
27 S1 p. 145-
1 p.
artikel
480 P093 Levormeloxifene, a non-steroidal estrogen receptor therapeutic, prevents bone loss, reduces serum cholesterol, and has differentiated uterine, effects in the ovariectomized rat Bain, S.
1996
27 S1 p. 144-
1 p.
artikel
481 P098 Levormeloxifene, a non-steroidal partial oestrogen receptor agonist, is a vasodilator in vivo and in vitro Shalmi, M.
1996
27 S1 p. 146-
1 p.
artikel
482 P182 Lipid and lipoprotein effects of transdermal and oral oestrogens: A randomised double-blind double-dummy placebo-controlled study Ross, D
1996
27 S1 p. 173-174
2 p.
artikel
483 P245 Long-term administration of tibolone is not associated with endometrial proliferation Kicovic, PM
1996
27 S1 p. 193-
1 p.
artikel
484 P001 Long-term effect of elcatonin on lumbar BMD in postmenopausal women Wu, YY
1996
27 S1 p. 117-
1 p.
artikel
485 P282 Long term effects of cyclic-combined conjugated estrogens and dydrogesterone in the treatment of postmenopausal syndrome Gambacciani, M
1996
27 S1 p. 204-
1 p.
artikel
486 P255 Long-term effects of different hormone replacement therapy regimens on the endometrium Dogany, M.
1996
27 S1 p. 195-
1 p.
artikel
487 P012 Long term effects of kliogest® (kliofem®) on bone turnover in postmenopausal women McKay Hart, D
1996
27 S1 p. 119-
1 p.
artikel
488 P181 Long-term effects of postmenopausal hormone replacement therapy on serum lipids and lipoproteins Lahdenperä, A
1996
27 S1 p. 173-
1 p.
artikel
489 P190 Long term hormonal replacement therapy (5 years) and lipid profile changes Castelo-Branco, C.
1996
27 S1 p. 176-
1 p.
artikel
490 P192 Mammary and metabolic effects related with tamoxifen treatment in postmenopausal women Pérez-López, F.R.
1996
27 S1 p. 177-
1 p.
artikel
491 P306 Management of the menopause with continuous HRT Signorile, PG
1996
27 S1 p. 211-
1 p.
artikel
492 P046 Markers of collagen biosynthesis and degradation during hormonal replacement therapy Jakowicki, J.A
1996
27 S1 p. 129-
1 p.
artikel
493 P269 Menopausal complaints: Effect of the type of menopause Möröy, P.
1996
27 S1 p. 200-
1 p.
artikel
494 P218 Menopausal symptoms and psycho-social influences in family relationship Horiguchi, F
1996
27 S1 p. 184-
1 p.
artikel
495 P308 Menopausal women treated with livial Serebrennikova, KG
1996
27 S1 p. 212-
1 p.
artikel
496 P151 Menopause and impaired endothelial function in caucasian but not in Chinese women McCrohon, JA
1996
27 S1 p. 164-
1 p.
artikel
497 P049 Menopause clinic-compliance on HRT Beljic, T.
1996
27 S1 p. 131-
1 p.
artikel
498 P297 25MG oestradiol implants and 1MG norethisterone as continuous combined HRT in the over 60's Panay, N.
1996
27 S1 p. 208-209
2 p.
artikel
499 P092 MIB 1 and bel-2 immunohistochemistry -a basis for a reproducible evaluation of the endometrium during HRT Karlsson, K
1996
27 S1 p. 144-
1 p.
artikel
500 P057 Mid life health survey of medical graduates from 1975 Murkies, AL
1996
27 S1 p. 133-
1 p.
artikel
501 P054 Monitoring of patients on hormone replacement therapy (HRT) within the primary care setting Tanna, NK
1996
27 S1 p. 132-
1 p.
artikel
502 P280 Muscle/joint pains and vasomotor symptoms: Two HRT regimens compared Oldenhave, A.
1996
27 S1 p. 203-
1 p.
artikel
503 P334 Myoma uteri significantly delays the age at menopause Tamada, T
1996
27 S1 p. 219-
1 p.
artikel
504 P066 Neuroendocrine control of thyroid function during aging in women Rossmanith, WG
1996
27 S1 p. 136-
1 p.
artikel
505 P211 New psychosocial menopause instrument-a resource for coping and consulting Schultz-Zehden, B
1996
27 S1 p. 183-
1 p.
artikel
506 P087 Norethindrone acetate (NETA) enhances the antiatherogenic effects of 17β-estradiol (E2) in ovariectomized cholesterol-fed rabbits Alexandersen, P.
1996
27 S1 p. 143-
1 p.
artikel
507 P137 17β-Oestradiol inhibits intimal hyperplasia in cultured human blood vessels Akkad, AA
1996
27 S1 p. 159-
1 p.
artikel
508 P107 Oestrogen deprivation at puberty a case presentation Jan, WJ
1996
27 S1 p. 149-
1 p.
artikel
509 P159 Oestrogen improves dysfunction of the frontocortico-striatal network (FCSN) during menopause Al-Azzawi, F
1996
27 S1 p. 166-
1 p.
artikel
510 P239 Oestrogen receptor and heat shock protein 27 expression during the late “pseudo-luteal” phase of a HRT regimen: Adequate oestrogenic priming Bell, SC
1996
27 S1 p. 191-
1 p.
artikel
511 P200 Oncological aspects of HRT Szabó, B
1996
27 S1 p. 179-
1 p.
artikel
512 P274 Oral testosterone — A viable alternative to injection or implant Heather Bartram, DR
1996
27 S1 p. 202-
1 p.
artikel
513 P013 Oral versus transdermal estrogen: effects on postmenopausal bone loss Bruschi, F.
1996
27 S1 p. 120-
1 p.
artikel
514 P036 Pattern of surgical menopausal bone loss Chittacharoen, A.
1996
27 S1 p. 127-
1 p.
artikel
515 P292 Percutaneous micronized progesterone pharmacocinetic Valls-Llobet, C.
1996
27 S1 p. 207-
1 p.
artikel
516 P295 Pharmacokinetics of estradiol blood content obtained with S21102, a new 7-day patch Lhote, O
1996
27 S1 p. 208-
1 p.
artikel
517 P024 Physical activities of women in the menopause Vagic, N.
1996
27 S1 p. 123-
1 p.
artikel
518 P097 Physiological dose of estrogen regulates extrathymic T cells in female mice Yahata, T
1996
27 S1 p. 146-
1 p.
artikel
519 P309 Phytoestrogens — The alternative approach Georgiev, DB
1996
27 S1 p. 213-
1 p.
artikel
520 P016 Positive results of tibolone combined with sodium fluoride in the treatment of postmenopausal osteoporosis Avramides, A.
1996
27 S1 p. 120-121
2 p.
artikel
521 P278 Post-marketing surveillance of transdermal estradiol + norethisterone (estracombi) in the United Kingdom Jones, CW
1996
27 S1 p. 203-
1 p.
artikel
522 P177 Postmenopausal HRT with oral norethisterone: Does the route of administration of the oestrogen influence serum lipoprotein levels? Crook, D
1996
27 S1 p. 172-
1 p.
artikel
523 P331 Pregnancies in premenopausal women Maas, D.H.A.
1996
27 S1 p. 218-
1 p.
artikel
524 P328 Pregnancy outcome in ovum donation cycles Irvine, RE
1996
27 S1 p. 218-
1 p.
artikel
525 P279 Preliminary data on ten years follow-up of patients on estradiol implants versus equine estrogens Dramusic, V
1996
27 S1 p. 203-
1 p.
artikel
526 P032 Premature osteoporosis in women with Crohn's disease (CD) Al-Azzawi, F
1996
27 S1 p. 126-
1 p.
artikel
527 P155 Premenstrual syndrome and perimenopausal experiences: Is there a relationship Morse, CA
1996
27 S1 p. 165-
1 p.
artikel
528 P059 Prevalence of hormone replacement therapy in menopausal women Gülerman, C.
1996
27 S1 p. 133-
1 p.
artikel
529 P039 Prevalence of vertebral osteoporosis in relation to its risk factors in random sample of post-menopausal women Czekalski, S
1996
27 S1 p. 127-
1 p.
artikel
530 P014 Prevention of osteoporosis with estradiol valerate and cyproteronacetat in postmenopausal women Felsenberg, D
1996
27 S1 p. 120-
1 p.
artikel
531 P240 Progesterone receptor and alpha-2-PEG/PEP/PP14 expression during the late “pseudo-luteal” phase of a HRT regimen-deficient glandular maturation? Bell, SC
1996
27 S1 p. 191-
1 p.
artikel
532 P145 Progestin administration does not attenuate the antioxidant effect of estradiol valerate in postmenopausal women Dören, M
1996
27 S1 p. 162-
1 p.
artikel
533 P051 Prophylaxis programme of menopausal and post menopausal disorders in women in the gdansk region Szczurowicz, A.
1996
27 S1 p. 131-
1 p.
artikel
534 P215 Psychosocial factors and attitude to menopause affecting menopause-related symptoms Barth-Olofsson, AS
1996
27 S1 p. 184-
1 p.
artikel
535 P162 Quality of life of women aged from 45 to 65 years: The “Bailleul, Femmes dans la Ville” study Belaisch, J.
1996
27 S1 p. 167-
1 p.
artikel
536 P031 Quantitative ultrasound sonography at the calcaneus in gynaecology. A new promising method Hadji, P
1996
27 S1 p. 125-
1 p.
artikel
537 P327 Radiation accelerates the onset of menopause Soda, M
1996
27 S1 p. 217-
1 p.
artikel
538 P290 Randomised double-blind endometrial study of a vaginal progesterone gel in oestrogen-treated postmenopausal women Ross, D
1996
27 S1 p. 206-
1 p.
artikel
539 P029 Rapid bone loss in oophorectomized Thai women Taechakraichana, N
1996
27 S1 p. 125-
1 p.
artikel
540 P198 Results of mammographic screening in menopausal women Gülerman, C.
1996
27 S1 p. 179-
1 p.
artikel
541 P003 Results of the osteoporosis health beliefs scale (OHBS) baseline assessment from a phase III randomized clinical trial of selective estrogen receptor modulator compared with hormone replacement therapy Houpt, LS
1996
27 S1 p. 117-
1 p.
artikel
542 P333 Screening of asymptomatic ovarian, masses in post menopausal women Sener, A.B.
1996
27 S1 p. 219-
1 p.
artikel
543 P062 Serum and fatty tissue dehydroepiandrosterone (DHEA) concentrations in obese pre- and postmenopausal women Milewicz, A
1996
27 S1 p. 135-
1 p.
artikel
544 P084 Serum galanin, cholecystokinin, NPY and beta-endorphin (β-EP) in menopausal women with different history of obesity Milewicz, A
1996
27 S1 p. 142-
1 p.
artikel
545 P186 Serum lipid profile of surgical and natural postmenopausal turkish women Oransay, S.
1996
27 S1 p. 175-
1 p.
artikel
546 P171 Serum lipids and bone mass density before and after hormone replacement therapy Paver, J.
1996
27 S1 p. 170-
1 p.
artikel
547 P302 Severe mesenterial thrombosis can be a complication of continuously applied oestrogen and gestogen therapy Szendei, Gy
1996
27 S1 p. 210-
1 p.
artikel
548 P160 Sexual interest of postmenopausal women is associated with 5 alpha-reductase activity Kennedy, RG
1996
27 S1 p. 166-
1 p.
artikel
549 P156 Sexuality, hormones and the menopausal transition Dennerstein, L
1996
27 S1 p. 165-
1 p.
artikel
550 P081 Smoking influence on oestrogen levels of postmenopausal women in hormonal replacement therapy Wehba, S
1996
27 S1 p. 140-
1 p.
artikel
551 P232 Sonographic findings of uterus and ovaries in normal pre and postmenopausal women Jirapinvo, M.
1996
27 S1 p. 189-
1 p.
artikel
552 P312 Soy and hot flushes Pansini, F
1996
27 S1 p. 213-
1 p.
artikel
553 P080 Surveillance of menopausal women during HRT Boschitsch, E.
1996
27 S1 p. 140-
1 p.
artikel
554 P041 Tea consumption and bone mineral density in postmenopausal women Celikkanat, H.
1996
27 S1 p. 128-
1 p.
artikel
555 P317 The alternative treatment seeker-who wishes to avoid Hormone Replacement Therapy and why? Beer, S.L.
1996
27 S1 p. 215-
1 p.
artikel
556 P252 The assessment of inter and intra observer variability in the measurement of endometrial depth by transvaginal ultrasound in healthy asymptomatic postmenopausal women Ballard, PA
1996
27 S1 p. 195-
1 p.
artikel
557 P234 The bleeding patterns in three hormone replacement therapy (HRT) regimens: The effect of a hypo-oestrogenic state? Al-Azzawi, F
1996
27 S1 p. 190-
1 p.
artikel
558 P106 The characteristic of the decreased bone mass in premature ovarian failure Lin, SO
1996
27 S1 p. 149-
1 p.
artikel
559 P164 The characteristics of menopausal patients taking psychiatric help Özsahin, A.
1996
27 S1 p. 167-
1 p.
artikel
560 P261 The effectiveness of hormone in relieving menopausal symptoms Panyakhamlerd, K
1996
27 S1 p. 198-
1 p.
artikel
561 P175 The effect of bilateral oophorectomy on Lp(a) plasma levels in postmenopausal women Duen˜as, JL
1996
27 S1 p. 171-
1 p.
artikel
562 P045 The effect of body weight on mineral density of each vertebral bone with in perimenopausal women Ohtsuka, S.
1996
27 S1 p. 129-
1 p.
artikel
563 P313 The effect of coumestrol and zearalanol on bone loss in the oophorectomized rat Draper, C.R.
1996
27 S1 p. 214-
1 p.
artikel
564 P260 The effect of endometrium in postmenopausal women receiving hormone replacement therapy alternative to oral therapy Ottanelli, S.
1996
27 S1 p. 197-
1 p.
artikel
565 P157 The effect of hormonal replacement therapy on female sexuality in postmenopausal period Borovsky, M
1996
27 S1 p. 165-
1 p.
artikel
566 P174 The effect of HRT on Lp(a) plasma levels Dueflas, JL
1996
27 S1 p. 171-
1 p.
artikel
567 P123 The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) Omodei, U.
1996
27 S1 p. 155-
1 p.
artikel
568 P320 The effect of isoflavones on menopausal symptoms Eden, JA
1996
27 S1 p. 215-
1 p.
artikel
569 P071 The effect of klimonorm on liver function and the menopausal syndrome Szlachcic, MJ
1996
27 S1 p. 137-
1 p.
artikel
570 P073 The effect of menopause on serum uric acid levels in non-obese healthy women Wingrove, CS
1996
27 S1 p. 138-
1 p.
artikel
571 P208 The effect of oestrogen and vitamin E treatment on the maturation index of cervicovaginal smear Doganay, M.
1996
27 S1 p. 181-
1 p.
artikel
572 P091 The effect of ovarian hormone on the bone loss in oophorectomized rats Kasai, Y
1996
27 S1 p. 144-
1 p.
artikel
573 P126 The effect of postmenopausal hormone replacement therapy on blood pressure in the short term Grassini, E
1996
27 S1 p. 156-
1 p.
artikel
574 P113 The effect of sex steroids on uterine artery blood flow in menopausal women: A preliminary report Baziad, A
1996
27 S1 p. 152-
1 p.
artikel
575 P249 The effect of tibolone (livial) on uterine fibroids in postmenopausal women Gregoriou, O.
1996
27 S1 p. 194-
1 p.
artikel
576 P118 The effect of tibolone on heart function of postmenopausal women with niddm Beljic, T.
1996
27 S1 p. 153-
1 p.
artikel
577 P115 The effect of transdermal estro-progestogen therapy on cardiovascular hemodynamic in healthy postmenopausal women Bohdanowicz-Pawlak, A
1996
27 S1 p. 153-
1 p.
artikel
578 P125 The effects of changing from mestranol to 17-beta oestradiol on blood coagulation and fibrinolysis in post menopausal women Cumming, G.
1996
27 S1 p. 155-
1 p.
artikel
579 P102 The effects of 17-β estradiol, medroxyprogesterone acetate and parathyroid hormone on akaline phosphatase activity in the osteoblastic cell line ros 17/2.8-5 Cho, SH
1996
27 S1 p. 147-
1 p.
artikel
580 P077 The effects of hormone replacement therapy (HRT) on exercise performance in postmenopausal women Stojanovska, L
1996
27 S1 p. 139-
1 p.
artikel
581 P187 The effects of hormone replacement therapy on serum concentrations of lipoprotein (a), angiotensin converting enzyme and insulin in postmenopause Seckin, NC
1996
27 S1 p. 175-
1 p.
artikel
582 P072 The effects of long term oestrogen on body fat distribution and lipid profiles Calder, AL
1996
27 S1 p. 138-
1 p.
artikel
583 P076 The effects of oral oestradiol with either sequential or continuous neta on glucose and insulin responses to oGTT in postmenopausal women Balint-Peric, Lj.A.
1996
27 S1 p. 139-
1 p.
artikel
584 P277 The effects of two different HRT regimensoral and transdermal - on the Hungarian postmenopausal women Fulop, V
1996
27 S1 p. 203-
1 p.
artikel
585 P085 The establishment of sensitive measurement of PTH receptor mRNA using competitive PCR with internal standard Miyamoto, S
1996
27 S1 p. 142-
1 p.
artikel
586 P083 The estimation of estracomb TTS influence on chosen biochemical parameters of carbohydrate, fat and hormonal metabolism Poreba, R.
1996
27 S1 p. 141-
1 p.
artikel
587 P271 The estimation of kupperman's index by applying estracomb TTS preparation Ciszek, V.
1996
27 S1 p. 200-
1 p.
artikel
588 P219 The experience and knowledge of mengpausal women in rural south Australia Murtagh, MJ
1996
27 S1 p. 185-
1 p.
artikel
589 P033 The health impact of self referral bone densitometry Kennedy, RG
1996
27 S1 p. 126-
1 p.
artikel
590 P141 The influence of age and serum oestradiol levels on resistance to blood flow in the internal carotid artery in postmenopausal women Marsh, MS
1996
27 S1 p. 160-
1 p.
artikel
591 P143 The influence of hormonal replacement therapy on blood flow Debski, R
1996
27 S1 p. 161-
1 p.
artikel
592 P128 The influence of hormone replacement therapy on the thickness of carotid artery wall in postmenopausal women: Measurement with a high-frequency ultrasonography unit Sator, MO
1996
27 S1 p. 156-
1 p.
artikel
593 P324 The influence of hormone therapy of the intraocular pressure in menopausal women Sator, MO
1996
27 S1 p. 216-
1 p.
artikel
594 P154 The influence, of HRT on cardiovascular system in postmenopausal women Smethic, V.
1996
27 S1 p. 164-
1 p.
artikel
595 P170 The influence of HRT on lipids and lipoproteins metabolism and selected parameters of coagulation in perimenopausal women Gadomska, H.
1996
27 S1 p. 170-
1 p.
artikel
596 P188 The influence of ovariectomy on serum lipoproteins in postmenopausal women Jakowicki, J.A.
1996
27 S1 p. 176-
1 p.
artikel
597 P147 The influence of progestins on normotensive & hypertensive menopausal women under hormone replacement therapy Pramparo, PC
1996
27 S1 p. 162-
1 p.
artikel
598 P088 The involvement of IL-6 receptor and GP130 in osteoclast differentiation and function in postmenopause Gao, Y
1996
27 S1 p. 143-
1 p.
artikel
599 P214 The Italian Climacteric Research Group (ICARUS) study de Aloysio, D
1996
27 S1 p. 183-
1 p.
artikel
600 P056 The jean hailes foundation-women's health education program as a reproducible model Davidson, G.A.
1996
27 S1 p. 132-
1 p.
artikel
601 P311 The measurement of urinary isoflavone levels by high-performance liquid chromatographic assay in Chinese menopausal women Roach, VJ
1996
27 S1 p. 213-
1 p.
artikel
602 P273 The menopause rating scale (MRS II) - clusters of menopausal symptoms Schneider, HPG
1996
27 S1 p. 201-
1 p.
artikel
603 P229 The morphological and biochemical response of the endometrium to two “period-free” hormone replacement therapy Okon, MA
1996
27 S1 p. 188-
1 p.
artikel
604 P213 The natural history of the menopausal transition in australian born women: An update from the melbourne women's midlife health project Dudley, E
1996
27 S1 p. 183-
1 p.
artikel
605 P030 The present state of the special out-patient ward (the menopause ward) in our hospital Komai, H
1996
27 S1 p. 125-
1 p.
artikel
606 P078 The prevalence and assessment of abnormal thyroid function tests in postmenopausal women not taking hormone replacement Bozich, TM
1996
27 S1 p. 139-
1 p.
artikel
607 P233 The relation between dydrogesterone dosage and vaginal bleeding pattern in sequentially combined HRT van de Weijer, PHM
1996
27 S1 p. 189-
1 p.
artikel
608 P151 The relation between hormone replacement therapy and risk factors for cardiovascular disease in postmenopausal women Traianos, B.
1996
27 S1 p. 163-
1 p.
artikel
609 P332 The role of routine ultrasound in assistance of postmenopausal women with emphasis on adnexal mass Pedro, AO
1996
27 S1 p. 219-
1 p.
artikel
610 P053 The role of the community pharmacist in HRT monitoring Tanna, NK
1996
27 S1 p. 132-
1 p.
artikel
611 P289 The UK kliogest (kliofem) multicentre study: Organisation and design Barlow, D
1996
27 S1 p. 206-
1 p.
artikel
612 P110 The use of 20MHz ultrasound for assessing the efficacy of HRT on the skin Cheung, L.
1996
27 S1 p. 151-
1 p.
artikel
613 P038 Tibial ultrasound velocity in women with polycystic ovary Hsu, C-C
1996
27 S1 p. 127-
1 p.
artikel
614 P109 Tibial ultrasound velocity in women with premature ovarian failure Huang, K-E
1996
27 S1 p. 150-
1 p.
artikel
615 P246 Tibolone: Dose-response analysis of uterine bleedings in a multicentre placebo-controlled study Kicovic, PM
1996
27 S1 p. 193-
1 p.
artikel
616 P304 Transdermal estradiol replacement using chlor-madinone acetate as sequential progestogen Mueck, AO
1996
27 S1 p. 211-
1 p.
artikel
617 P251 Transvaginal ultrasound and transvaginal hysterosonography (Saline infusion) in the evaluation of the endometrium in fibroid uterus Surkont, G
1996
27 S1 p. 194-
1 p.
artikel
618 P323 Treatment of keratoconjunctivitis sicca during menopause with topical 17-β-estradiol in comparison with a tear substitute Sator, MO
1996
27 S1 p. 216-
1 p.
artikel
619 P272 Treatment of menopausal syndrome by beevenom and bee propolis (a new modality) Ali Farid, A
1996
27 S1 p. 201-
1 p.
artikel
620 P305 Treatment with testosteronundecanoate in postmenopausal women — A pharmacological study Flöter, A
1996
27 S1 p. 211-
1 p.
artikel
621 P337 Tubal ligation and long term health outcomes: Retrospective information in the melbourne women's midlife study Taffe, JR
1996
27 S1 p. 220-
1 p.
artikel
622 P224 Ultrasound screening in postmenopausal women Georgiev, DB
1996
27 S1 p. 187-
1 p.
artikel
623 P131 Urinary surrogate-markers for vascular effects of transdermal and oral estradiol in, postmenopausal women Lippert, TH
1996
27 S1 p. 157-
1 p.
artikel
624 P202 Urogenital symptoms and resulting discomfort in non-institutionalized dutch women aged 50 to 75 years van de Weiler, PHM
1996
27 S1 p. 180-
1 p.
artikel
625 P303 Use of a levonorgestrel releasing intrauterine device in substitutive estrogenic therapy in menopause Becorpi, A
1996
27 S1 p. 211-
1 p.
artikel
626 P148 Use of micronised progesterone in women under estrogen replacement therapy: Oral vs vaginal route Figueroa-Casas, PR
1996
27 S1 p. 89-
1 p.
artikel
627 P019 Use of nasal calcitonin in severe osteoporotic post menopausal women: Metabolic action, bone density fluctuations, possible prevention of future fractures David, A
1996
27 S1 p. 122-
1 p.
artikel
628 P152 Uterine notching in the menopause reflects the arterial status and the arterial effect of HRT Jakab Jr, A
1996
27 S1 p. 164-
1 p.
artikel
629 P250 Vaginal sonography of the endometrium in postmenopausal women on tilobone or low-dose estrogen treatment: A comparison 1996
27 S1 p. 194-
1 p.
artikel
630 P244 Variation between pathologists in the reporting of endometrial histology with combination oestrogen/progestogen therapies Whitchead, MI
1996
27 S1 p. 192-
1 p.
artikel
631 P184 Variations of lipids (L) and blood pressure (BP) during combined continuous hormone replacement therapy (CC-HRT) in postmenopausal women(PW) Martino, M
1996
27 S1 p. 174-175
2 p.
artikel
632 P205 Viral vulvo-vaginitis masquerading as atrophic change in postmenopausal women Cooper, A
1996
27 S1 p. 181-
1 p.
artikel
633 P074 Weight gain and hormone replacement therapy: An educational approach to patient concerns Lanzarone, VF
1996
27 S1 p. 138-
1 p.
artikel
634 P281 Well-being and vasomotor complaints: Two HRT regimens compared Oldenhave, A.
1996
27 S1 p. 204-
1 p.
artikel
635 P058 What is involved in co-ordinating and implementing a multicentre hormone replacement therapy (HRT) clinical trial?-An Australian perspective Hangan, JT
1996
27 S1 p. 133-
1 p.
artikel
636 P105 Women referred to a specialist menopause clinic with premature ovarian failure Birdsall, MA
1996
27 S1 p. 149-
1 p.
artikel
637 P329 Zift versus et in a randomised assessor blind trial in ovuum donation cycles Irvine, RE
1996
27 S1 p. 218-
1 p.
artikel
638 S25 Age, estrogens and cognitive function Erkkola, R
1996
27 S1 p. 30-
1 p.
artikel
639 S41 A general practitioner's outlook on long term HRT and the GP/specialist relationship Drew, SV
1996
27 S1 p. 35-
1 p.
artikel
640 S03 Alendronate prevents vertebral and clinical fractures in women with existing vertebral fractures: Results of the fracture intervention trial Karpf, DB
1996
27 S1 p. 23-24
2 p.
artikel
641 S21 Alternatives to hormone replacement therapy: Antiresorptive therapy (bisphosphonates and calcitonin) Seeman, Ego
1996
27 S1 p. 29-
1 p.
artikel
642 S22 Alternatives to HRT: What is the role of calcium and vitamin D? Ringe, J.D.
1996
27 S1 p. 29-30
2 p.
artikel
643 S54 Apnea in postmenopausal women Naftolin, F
1996
27 S1 p. 40-
1 p.
artikel
644 S36 Bleeding patterns and endometrial histology with sequential HRT Sturdee, DW
1996
27 S1 p. 34-
1 p.
artikel
645 S38 Can we predict bleeding patterns? Ulrich, LG
1996
27 S1 p. 35-
1 p.
artikel
646 S07 Cardiac hemodynamics, menopause and HRT Pines, A
1996
27 S1 p. 25-
1 p.
artikel
647 S01 Clinical aspects of patient identification Delmas, P.D.
1996
27 S1 p. 23-
1 p.
artikel
648 S16 Combination continuous therapy-effect on lipid profiles Silberberg, S.
1996
27 S1 p. 27-
1 p.
artikel
649 S15 Combination continuous therapy-what is the optimal MPA dose? Effect on bleeding profiles and endometrial histology Webster, M
1996
27 S1 p. 27-
1 p.
artikel
650 S13 Combination continuous therapy-what is the optimal (MPA) dose? Structure of the study Smith, Howard
1996
27 S1 p. 26-
1 p.
artikel
651 S17 Continuous oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy-a study of bone density over 2 years Nand, S.L.
1996
27 S1 p. 27-
1 p.
artikel
652 S26 Divigel/sandrena-clinical benefits Viitanen, AT
1996
27 S1 p. 31-
1 p.
artikel
653 S30 Educational efforts towards better recognition of urogenital ageing Dören, M
1996
27 S1 p. 32-
1 p.
artikel
654 S14 Efficacy of ogen/provera regimens Baber, RJ
1996
27 S1 p. 26-
1 p.
artikel
655 S39 Endometrial response to continuouscombined HRT Wells, M
1996
27 S1 p. 35-
1 p.
artikel
656 S42 Estrogen and memory in women Sherwin, BB
1996
27 S1 p. 36-
1 p.
artikel
657 S44 Estrogen replacement in women treated for depression and dementia Schneider, LS
1996
27 S1 p. 36-
1 p.
artikel
658 S10 Evaluation of the effects of HRT on the endometrium-the view from the microscope Bergeron, C
1996
27 S1 p. 25-
1 p.
artikel
659 S11 Evaluation of the endometrium by ultrasound the view from the screen Hänggi, W
1996
27 S1 p. 26-
1 p.
artikel
660 S24 Haemostasis and HRT Kroon, U-B
1996
27 S1 p. 30-
1 p.
artikel
661 S50 Hormone replacement therapy and carbohydrate metabolism Gaspard, UJ
1996
27 S1 p. 38-
1 p.
artikel
662 S52 Hormone replacement therapy and haemostatic factors Winkler, UH
1996
27 S1 p. 39-
1 p.
artikel
663 S51 Hormone replacement therapy and lipid metabolism Crook, D
1996
27 S1 p. 39-
1 p.
artikel
664 S58 Hormone replacement therapy in women over 60. Management of cancer risks Foidart, J.M.
1996
27 S1 p. 41-
1 p.
artikel
665 S56 Hormone replacement therapy women over 60 management of osteoporosis prevention Palacios, S.
1996
27 S1 p. 40-41
2 p.
artikel
666 S59 HRT in women over 60 management of compliance de Lignieres, Bruno
1996
27 S1 p. 42-
1 p.
artikel
667 S34 Identifying the high-risk post-menopausal woman Barrett-Connor, Elizabeth
1996
27 S1 p. 34-
1 p.
artikel
668 S27 Introduction to discussion of urogenital ageing and its treatment Nachtigall, Lila E
1996
27 S1 p. 32-
1 p.
artikel
669 S04 Introduction to vascular biology Celermajer, DS
1996
27 S1 p. 24-
1 p.
artikel
670 S06In vitro andin vivo effects of estrogen on nitric oxide and the endothelium Collins, P
1996
27 S1 p. 24-
1 p.
artikel
671 S05 In vitro and in vivo effects of estrogens on prostacyclin and throm☐ane and on other vasoactive compounds Mueck, AO
1996
27 S1 p. 24-
1 p.
artikel
672 S12 Livial (tibolone) and the specific endometrial response-the view from recent clinical studies Coelingh Bennink, HJT
1996
27 S1 p. 26-
1 p.
artikel
673 S23 Metabolic changes induced by peroral and percutaneous estrogen therapy Kesäniemi, YA
1996
27 S1 p. 30-
1 p.
artikel
674 S49 Metabolic determinants of atherosclerosis Krauss, RM
1996
27 S1 p. 38-
1 p.
artikel
675 S02 Non-hormonal treatment for postmenopausal osteoporosis: The role of bisphosphonates Fleisch, H.
1996
27 S1 p. 23-
1 p.
artikel
676 S33 Osteoporosis: An overview Lindsay, R.
1996
27 S1 p. 33-
1 p.
artikel
677 S43 P06.022-a prospective study of estrogen replacement therapy and the risk of developing alzheimer's disease in the baltimore longitudinal study of aging Morrison, A
1996
27 S1 p. 36-
1 p.
artikel
678 S08 Peripheral vascular changes Cooper, A
1996
27 S1 p. 25-
1 p.
artikel
679 S09 Post-menopausal bleeding-the view from the clinic Studd, J
1996
27 S1 p. 25-
1 p.
artikel
680 S46 Premature menopause: Consequences to the women Davis, Susan R.
1996
27 S1 p. 37-
1 p.
artikel
681 S20 Prevention of osteoporosis with estrogens, its analogues and progestogens: What is new? Purdie, DW
1996
27 S1 p. 28-29
2 p.
artikel
682 S53 Role of estrogens in falls and fractures Birge, SB
1996
27 S1 p. 39-
1 p.
artikel
683 S18 Side effects - compliance O'Connor, Vivienne
1996
27 S1 p. 28-
1 p.
artikel
684 S40 Side effects in women using Kliogest (Kliofem) in the UK multicentre study Barlow, D
1996
27 S1 p. 35-
1 p.
artikel
685 S55 Targeted drug delivery in gynecology: Vaginal progesterone (P) and the first uterine pass effect Bulletti, C.
1996
27 S1 p. 40-
1 p.
artikel
686 S45 The cause of premature menopause Godfree, VA
1996
27 S1 p. 36-37
2 p.
artikel
687 S31 The clinical platform for estring Bachmann, G.
1996
27 S1 p. 33-
1 p.
artikel
688 S35 The clinical promise of the selective estrogen receptor modulator, raloxifene HCI and the postmenopausal woman Anderson, PW
1996
27 S1 p. 34-
1 p.
artikel
689 S29 The female perspective: Women's attitudes towards urogenital ageing Wright, HJ
1996
27 S1 p. 32-
1 p.
artikel
690 S32 The health economics of osteoporosis and hormone replacement therapy Prince, R.
1996
27 S1 p. 33-
1 p.
artikel
691 S47 The management of bone loss in young women with estrogen deficiency Delmas, PD
1996
27 S1 p. 37-
1 p.
artikel
692 S19 The new definition of osteoporosis and its implications for bone mass measurement in women Delmas, PD
1996
27 S1 p. 28-
1 p.
artikel
693 S28 Urogenital ageing-a hidden problem Göran, Samsioe
1996
27 S1 p. 32-
1 p.
artikel
694 S37 Why postmenopausal women with an atrophic endometrium bleed Smith, SK
1996
27 S1 p. 34-
1 p.
artikel
695 S48 Younger women: Is there ever a need for HRT? dealing with the complications of therapy Dören, M
1996
27 S1 p. 37-
1 p.
artikel
                             695 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland